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ABSTRACT 
 
A NOVEL AND RAPID STAPHYLOCOCCUS AUREUS BACTERIAL 
IDENTIFICATION METHOD UTILIZING IMMUNOMAGNETIC BEADS AND 
SINGLE CELL LASER-LIGHT SCATTERING 
By 
Kaylagh Hollen 
Staphylococcus aureus (Gram-positive cocci) is the most commonly isolated 
human associated bacterial pathogen. It plays an important role in skin and soft-tissue 
infections, pneumonia, endocarditis, osteomyelitis, foreign-body infections, and sepsis. S. 
aureus diagnosis and treatment includes identification, susceptibility testing, screening 
for methicillin resistance, and glycopeptide resistance, which requires a minimum of 24-
48 hours depending upon the method. With this in mind, previous studies suggest that 
faster pathogen identification has been linked to improved patient outcomes. Improved 
patient outcomes including a reduction in hospitalization time, decreased risk of 
nosocomial infections, and decreased in medical costs. The impact of faster identification 
on patient outcome has led us to develop an alternative method of S. aureus identification 
via ImmunoMagnetic Separation and laser-light scattering identification technology. 
With this method, we hypothesized that anti-Protein A conjugated to magnetic 
DynaBeads (also referred to as, anti-Protein A DynaBeads) could bind to surface Protein 
A on S. aureus from swab sample and facilitate their isolation upon exposure to a 
magnetic field within a 4-8 hour procedure. S. aureus cells isolated by IMS would then 
be accurately identified using laser-light scattering technology in less than 5 minutes.  
ii 
 
Prior to the development of these methods, MIT identification accuracy analysis 
was conducted and displayed that both laboratory and clinical Staphylococcus species 
strains identified at a rate greater than 95% and negative control strains identified at a rate 
less than 1%. After confirming MIT accuracy, we developed IMS capture methods in 
order to bypass the lengthy step of growing bacteria on agar plates. We then evaluated 
these methods for specificity and capture efficiency for S. aureus. Our S. aureus IMS 
methods displayed statistically significant (P < 0.001) specificity for S. aureus and 
capture efficiency greater than 80%. After IMS capture, an enrichment step was 
developed prior to laser-light identification, in order to obtain the necessary number of 
bacteria cells within a sample for proper laser-light scattering identification (1,000 
bacteria cells per milliliter). Optimal conditions for IMS capture, enrichment, and laser-
light identification methods were established and utilized to isolate and identify S. aureus 
from both pure and mixed cultures in 4-8 hours. With these methods we were able to 
successfully capture and identify S. aureus in less than 8 hours. In typical wound 
infections, specimens are collected from these types of infection sites on sterile swabs.  
Furthermore, we utilized our methods on swab collected specimens, where we 
demonstrated that we could successfully capture and identify S. aureus in less than 8 
hours. The combination of IMS and laser-light identification gives a rapid and accurate 
identification in less than 8 hours, which is significantly less than traditional culture 
based identification methods.  
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CHAPTER ONE: INTRODUCTION AND LITERATURE REVIEW 
 
 
 
 
Staphylococcus aureus 
 
Staphylococcus aureus is the most commonly isolated human associated bacterial 
pathogen. It plays an important role in skin and soft-tissue infections, pneumonia, 
endocarditis, osteomyelitis, foreign-body infections, and sepsis 21,69. S. aureus is 
characterized as a large Gram-positive coccus (1 µm in diameter) that grows in grape-like 
clusters 21. Its colonies are pigmented yellow or golden but some colonies may also be 
white. Unlike many other species of the Staphylococcus genus, S. aureus secretes an 
enzyme, coagulase, which clots plasma. S. aureus is best distinguished from other 
Staphylococcus species by the presence of coagulase and mannitol fermentation. S. 
aureus is one of the most resilient of the non-spore forming bacteria and 
characteristically survives on dry, inanimate objects for up to 7 days to 7 months 47,51.   
Humans are the main reservoir for S. aureus. Approximately 30% of healthy 
individuals are colonized by S. aureus and up to 90% of people are colonized during 
one’s lifetime. It is believed that 20% are persistent carriers, 60% are intermittent 
carriers, and 20% are non-carriers who rarely harbor the bacteria 32. S. aureus commonly 
colonizes in the nares of humans; however, it can also be found on the skin, oropharynx, 
vagina, and in feces. Due to its ability to produce lipases and glycerol ester hydrolases, S. 
aureus has the ability to grow at high salt and lipid concentrations enabling it to colonize 
the skin. In addition to human colonization, it can also survive on domestic animals, 
livestock, and inanimate surfaces and objects such as clothing, bedding, and other hard 
surfaces 21,69.  
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S. aureus as a pathogen 
 
S. aureus is the most common pus producing (pyogenic) bacteria that can cause 
human disease. S. aureus can generate a wide range of infections including: abscesses at 
any site of the body, pneumonia, osteomyelitis, endocarditis, toxic shock syndrome 
(TSS), Staphylococcal scalded skin syndrome (SSSS), and Staphylococcal food 
poisoning (SFP) 21,69. S. aureus is spread from person to person, usually through direct 
contact or upper respiratory aerosols during bacterial infections. S. aureus generally does 
not penetrate into deep tissues unless there is damage to the skin. Skin damage such as 
burns, cuts, lacerations, insect bites, or surgical intervention may result in the entry of S. 
aureus into the mucosal membranes of the host. If S. aureus is present in large 
concentrations, there is a potential for spontaneous entry and infection. Poor hygiene and 
prolonged skin moisture may increase the growth rate of S. aureus and lead to 
spontaneous infection. It is not known if S. aureus spontaneously penetrates the skin or if 
it enters through damaged skin 69. If S. aureus does penetrate the skin and enter into deep 
tissues, there are several factors that could contribute to its survival including: the 
concentration of entering bacteria, the site of entry, the speed of the hosts immune 
response, and the immune system strength of the host 69. S. aureus infections are usually 
stopped when the initial inoculum is small and an individual’s immune system is 
competent. If an infection does occur, the damage most commonly results in abscesses. 
Abscesses are collections of pus. Abscesses in the skin are referred to as boils or 
furuncles and multiple interconnected abscesses are called carbuncles 69.  
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Methicillin-resistant S. aureus (MRSA) 
In 1961, soon after the introduction of the antibiotic methicillin, the first β-
lactamase-resistant penicillin strains of S. aureus were also found to be resistant to 
methicillin 21,46. From the 1960s to the early 1970s, methicillin-resistant S. aureus 
(MRSA) infections were largely found in hospital-acquired settings (HA-MRSA). HA-
MRSA strains are largely isolated from immunocompromised individuals or individuals 
exposed to health care settings.  HA-MRSA strains tend to cause pneumonia, bacteremia, 
and invasive infections 21. Today, MRSA causes the majority of nosocomial infections 
worldwide 36. HA-MRSA infections are defined as a patient whose MRSA isolate was 
cultured more than 48 hours after admission and who had a history of hospitalization, 
surgery, dialysis, or residence in a long-term healthcare facility within 6 months prior to 
the culture date, or who had an indwelling intravenous line, catheter, or any other 
percutaneous medical device present at the time the culture was taken 56. HA-MRSA 
carry a large Staphylococcal chromosomal cassette (SCC) mec which contains the 
signature mecA gene (type I, II, or III). MecA is a 2.1 kb gene that encodes for a 
transpeptidase, which results in 78-kDa cell-wall protein called Penicillin Binding Protein 
2a (PBP2a). PBP2a mediates continued peptidoglycan synthesis even when in the 
presence of β-lactams. β-lactam antibiotics bind to PBPs that are present on the surface of 
S. aureus, however PBP2a has evolved to have low binding affinity for these antibiotics, 
resulting in the continued growth of these strains 23,69. HA-MRSA mecA gene types vary 
in size and function, SCCmec I (34.3 kb) results in β-lactam resistance while, SCCmec II 
(53.0 kb) and SCCmec III (66.9 kb) result in resistance to multiple classes of antibiotics 
23.  HA-MRSA are often resistant to many classes of non-β-lactam antibiotics and rarely 
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carry the gene for Panton-Valentine leukocidin (PVL), which functions in neutrophil lysis 
21.  
Prior to the 1990s, MRSA infections were confined largely to patients and within 
health care settings; however, the rate of community-acquired MRSA (CA-MRSA) 
infections has increased immensely. A study conducted in 2005 found that greater than 
80% of all MRSA infections were attributed to CA-MRSA strains, as opposed to HA-
MRSA strains 54. CA-MRSA infections are defined as strains isolated in an outpatient 
setting, or isolated from patients within 48 hours of hospital admission. These patients 
must have no medical history of MRSA infection or colonization, and no medical history 
in the past year of either hospitalization, admission to a nursing home, or dialysis 56. 
These strains tend to be more virulent than HA-MRSA strains and CA-MRSA has begun 
to replace HA-MRSA in health care settings 44,50. It has been found that CA-MRSA 
patients often lacked risk factors known for patients with HA-MRSA infections. Those 
risk factors include, recent hospitalization, dialysis, nursing-home residence, or other co-
morbid conditions 44. CA-MRSA strains carry smaller SCCmec elements (type IV or V) 
compared to the HA-MRSA (type I, II, or III). The CA-MRSA SCCmec types vary in 
size which are, SCCmec IV (20.9-24.3 kb) and SCCmec V (28 kb). They also carry the 
mecA gene and are believed to be more genetically mobile. In addition, they also are 
resistant to fewer non-β-lactam antibiotics than HA-MRSA and tend to carry the gene for 
PVL. Groups that are at risk for CA-MRSA infections in the United States include: 
neonates, children beyond the neonatal period (daycare centers), athletes, household 
contacts of MRSA patients, emergency department patients, indigenous populations, 
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detainees in jail or prison, cystic fibrosis patients, military personnel, HIV patients, and 
veterinarians and livestock handlers 21.  
S. aureus virulence 
In a highly regulated manner, under appropriate conditions, S. aureus produces 
numerous virulence factors such as exotoxins and cell surface proteins. These virulence 
factors result in increased pathogenicity and survival within host cells 4,69. S. aureus has 
the ability to colonize the skin and mucosal surfaces by way of microbial surface 
components recognizing adhesive matrix molecules (MSCRAMMs), which enable S. 
aureus to bind to a wide variety of host surface proteins 69. The most prevalent group of 
cell wall-anchored proteins of S. aureus are the MSCRAMMs. MSCRAMMs are defined 
by their tandemly linked IgG-like folded domains and function in many diverse ways 28. 
Their functions include colonization of host tissues and the evasion of host defenses 28. 
Notable MSCRAMMs include: fibronectin-binding proteins, collagen binding proteins, 
and fibrinogen binding proteins. Fibronectin-binding proteins (FnbpA and FnbpB) are 
found on the surface of S. aureus and allow the bacteria to invade epithelial and 
endothelial cells. Fnbps also attach to exposed fibronectin in wounds leading to deep 
tissue infections 69. Collagen binding proteins (CBPs) function by binding collagen-rich 
tissues and prevent the classical pathway of complement activation 28. Clumping factors 
A and B function in fibrinogen binding and result in clot formation and endocarditis. 
Clumping factor A function in adhesion to immobilized fibrinogen resulting in immune 
evasion by binding soluble fibrinogen. Clumping factor B function in the adhesions to 
desquamated epithelial cells and result in nasal colonization 28. In addition to 
MSCRAMMs, other cell wall-anchored (CWA) proteins include those from the near iron 
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transporter (NEAT) motif family, the G5-E repeat family, the Three-helical bundle 
(Protein A), and structurally uncharacterized proteins.  
Protein A, regulated by the spa gene, is expressed on the surface of nearly all S. 
aureus strains and occupies approximately 7% of the S. aureus cell surface 30. Protein A 
is involved in the avoidance of phagocytosis of the host’s defense system. More 
specifically, Protein A binds the Fc regions of IgG thus preventing opsonization and 
subsequent phagocytosis 21. Protein A is expressed in both the secreted and membrane 
bound form so it can be released into the environment surrounding bacterial growth 
where it can bind free IgG antibodies 21,69. This protein possesses two Ig-binding 
activities: each of its five domains can bind either the Fc or Fab regions of IgG 
antibodies. The Fc region naturally functions in the binding of antigens for the 
complement system and the Fab region is responsible for antigen recognition 7. More 
specifically, Protein A binds the Fc site via the CH2 and CH3 interfaces and can also 
bind a variable region of the Fab region of the IgG heavy chain 33.  
The result of Protein A binding IgGs is the activation of tumor necrosis factor 
within the host and this can induce inflammation after triggering B-cell proliferation 21. 
Studies display that S. aureus strains lacking Protein A are phagocytized more efficiently 
in vitro and have overall decreased virulence in murine models of septic arthritis and 
pneumonia 59.  Protein A is encoded by the gene Spa. Spa, a growth stage dependent 
gene, is upregulated during the exponential growth phase and is down-regulated during 
the post-exponential phase of growth 59. There are numerous regulatory elements that 
have been shown to directly and indirectly regulate spa gene expression including Agr 
(RNAIII), Arl, MgrA, SarU, SarA, SarS, SarT, and XdrA.  Spa regulation is not only 
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associated with Protein A but many other networks that regulate a multitude of virulence 
factors in S. aureus, such as, exotoxins and β-lactam resistance 59.  
S. aureus secretes many enzymes and toxins that function in the battle with host 
immune cells 69.  One of those members is catalase, which functions by converting 
hydrogen peroxide to water, counteracting neutrophils’ ability to kill bacteria by the 
production of oxygen free radicals 69. Another S. aureus enzyme, coagulase, converts 
fibrinogen to fibrin preventing phagocytosis. In addition to enzymatic immune system 
evasion, secreted toxins are also utilized to aid in immune system avoidance by S. aureus.   
S. aureus possesses a group of toxins that targets cytoplasmic membranes of its 
host. These membrane-damaging toxins include four hemolysins (α, β, γ, and δ) and 
leukocidins. These toxins penetrate membranes causing the formation of pores within the 
host’s membrane. Two types of the membrane-damaging toxins are receptor-mediated 
toxins and non-receptor mediated toxins. Receptor mediated toxins show higher cell 
specificity than toxins not mediated by receptors. Receptor mediated toxins often play a 
role in lysis of red (hemolysin) and white blood cells (leukocidin) 65. Specific receptor-
mediated toxins include the α- and γ-toxins, PVL, and leukocidins LukED and LukAB. 
Hemolysin, or α-toxin, is lytic to red blood cells and multiple leukocytes, but not to 
neutrophils. The α-toxin is a secreted β-barrel pore-forming toxin that functions by 
binding to ADAM10 receptors of host cells resulting in apoptosis of those cells 28,65. The 
γ-toxin plays a role in the pathogenesis of TSS 63. PVL is a two-component pore-forming 
protein that can lyse neutrophils. PVL can be easily spread strain to strain by horizontal 
gene transfer via bacteriophages, which drastically increases the virulence of S. aureus 
strains. PVL is closely linked to CA-MRSA strains and it is estimated that 60-100% of 
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CA-MRSA strains carry the PVL genes 21.  S. aureus also possesses leukocidins, which 
function in neutrophil killing and escape, resulting in the promotion of its survival within 
the host. LukAB is a leukocidin that contributes to neutrophil killing by both external and 
internal interactions. LukAB can cause damage to neutrophils by directly binding to its 
cell surface. S. aureus can also cause damage to neutrophils from within the immune cell 
by secreting LukAB 61. LukED is a major S. aureus virulence factor involved in the 
promotion of disease progression during septic infection 3. LukED is produced during the 
course of human infection and has been linked to S. aureus associated impetigo and 
diarrhea 3,34 
In addition to receptor-mediated hemolysins and leukocidins, there are also toxins 
that are not regulated by receptors. These toxins are often less specific but still contribute 
to host cell membrane damage. The δ-toxin, part of a family of secreted peptides called 
the phenol-soluble modulins (PSMs), functions in non-specific cytolytic activity and the 
triggering of inflammatory responses 52. The role of β-toxin is unclear; however, it is 
believed to play an important role in biofilm formation, especially during endocarditis 
infections 69.  In addition to membrane-damaging toxin, S. aureus also possesses 
enterotoxins, which interfere with receptor function. Enterotoxins are secreted toxins (20-
30 kDa) that interfere with intestine function causing diarrhea and vomiting 40. These 
enterotoxins are also considered to be superantigens. Superantigens trigger T cell 
activation and proliferation without the need for antigen processing by allowing non-
specific interaction with T cell receptors 65. The mechanism for cytokine release for these 
toxins is not well known but the resulting conclusion is cell death by apoptosis for host 
immune cells 53. The most prevalent enterotoxins that S. aureus possesses are 
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Staphylococcal enterotoxin B (SEB), Staphylococcal enterotoxin C (SEC), and toxic 
shock syndrome toxin (TSST). Superantigen SEB causes cellular cytotoxicity by 
inducing inflammatory cytokine release with the potential to result in septic shock 53. 
Superantigen SEC has been linked to endocarditis, sepsis, and kidney damage when the 
SEC gene is found in CA-MRSA strains 75. TSST, the superantigen that causes TSS 
stimulates the release of IL-1, IL-2, TNF-α, and other cytokines which function as 
signaling molecules to mediate and regulate immunity and inflammation 63. In addition to 
the previously mentioned toxins, S. aureus is also equipped with other enzymes and 
toxins that function in the interference with the host’s immune system. Overall, S. aureus 
virulence and survival revolves around its ability to both damaging host cells and avoid 
rapid killing by host neutrophils.  
S. aureus diagnosis and treatment 
 
Recommendations for S. aureus diagnosis and treatment include identification, 
susceptibility testing, screening for MRSA, and glycopeptide resistance. Identification of 
S. aureus is traditionally achieved by coagulase tests or latex agglutination tests; 
however, identification can also be achieved by detection of Protein A production and 
heat-stable nucleases 8. Coagulase tests can be conducted in a test tube or on a slide. Test 
tube coagulase tests are used to identify the presence of bound or free coagulase within a 
sample. Slide coagulase tests are used to identify the presence of cell-bound clumping 
factor. Slide agglutination tests are very rapid but up to 15% of S. aureus strains are 
negative, so slide tests need to be confirmed with tube agglutination tests. 83 
Staphylococcus schleiferi, Staphylococcus lugdunensis, and Staphylococcus intermedius 
may give positive results in coagulase and clumping factor tests 89. Latex agglutination 
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tests detect for the presence of Protein A and/or clumping factor, and various surface 
antigens. There are additional biochemical test kits and automated instruments that are 
used to identify S. aureus; however, these methods are generally slower and more 
expensive than traditional agar-based identification methods. In contrast, other 
biochemical methods, including Staphychrom II and CHROMagar have been found to 
work better than tube coagulase identification tests 9,27. Staphychrom II is a two hour 
chromogenic test that uses human prothrombin and protease inhibitors, as well as a color 
indicator (yellow) to identify S. aureus 27. CHROMagar identifies S. aureus by growing 
the isolated strain on the medium. Colonies that appear pink are identified as S. aureus 9. 
In addition to traditional identification tests, S. aureus can be identified by 
deoxyribonuclease (DNase) tests and molecular tests. Diagnostic laboratories use of 
molecular tests for S. aureus identification is unlikely unless there is a high suspicion of a 
MRSA infection. Molecular tests are often conducted for confirmation or to determine 
susceptibility to methicillin/oxacillin; the combination of S. aureus identification and 
susceptibility reading allows for rapid identification of MRSA isolates 8. The majority of 
molecular based tests are PCR based and have species-specific targets. For MRSA 
strains, traditional targets are nuclease (nuc), coagulase (coa), Protein A (spa), femA, 
femB, Sa442, 16s rRNA and other surface-associated fibrinogen-binding protein genes 
31,58,86.  
For S. aureus skin infections, incision and drainage remains the primary therapy. 
In addition to incision and drainage, antimicrobial coverage for MRSA may also be 
necessary 10. S. aureus infections can be treated with antibiotics that target pathways 
essential for survival including: cell-wall synthesis, folic acid metabolism, and bacterial 
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protein synthesis. S. aureus tends to be resistant to penicillin and semi-sensitive to 
semisynthetic penicillins, such as nafcillin (methicillin-sensitive S. aureus, or MSSA). 
When determining the course of treatment, antibiotic administration should be guided by 
the susceptibility profile of the strain and the type of infection.  The Centers for Disease 
Control and Prevention (CDC) recommends clindamycin to treat serious S. aureus 
infections; however, a D-zone test should be performed in order to identify inducible 
clindamycin resistance in erythromycin-resistant S. aureus strains 11. D-zone tests are 
performed by disk diffusion by placing an erythromycin disk (15 µg) in proximity to a 
clindamycin disk (2 µg) on an agar plate that has been inoculated with a Staphylococcus 
species and incubated overnight. A flattening of the zone of inhibition around the 
clindamycin disk proximal to the erythromycin disk (producing a D shaped zone of 
inhibition) is considered a positive result. This indicates that erythromycin has induced 
clindamycin resistance 2. Tetracyclines, such as doxycycline and minocycline are also 
used to treat S. aureus skin infections, but are not recommended during pregnancy or for 
children under the age of eight. Rifampin is also used to treat S. aureus but only in 
combination with other agents. Linezolid can be utilized to treat complex skin infections, 
including MRSA; however, consulting an infectious disease specialist is suggested. When 
treating MRSA strains, these strains are resistant to all available β-lactam antibiotics 
(penicillins and cephalosporins). Fluoroquinolones and macrolides are also not optimal 
treatments for MRSA skin and soft tissue infections due to resistance or the potential of 
resistance development 11.     
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Other microbes utilized in this study 
 Many infections can be polymicrobial, and it is rare to find pathogenic organisms 
isolated from the human body in pure culture from the initial infection site. Negative 
control organisms that were used in this project were carefully picked with the intention 
of mimicking real-life conditions of mixed bacterial samples. Both skin infections and 
other potential contaminants were chosen in order to represent a realistic mixed sample. 
The following organisms were chosen in order to recapitulate a skin sample that might 
contain multiple bacteria: Staphylococcus epidermidis, Streptococcus pyogenes, and 
Micrococcus luteus, and Enterococcus faecalis. Staphylococcus epidermidis is a Gram-
positive cocci (0.8-1 µm) that generally appears in single cells or small clusters. S. 
epidermidis is found on the skin of most people but rarely causes disease in health 
individuals 21. Although S. epidermidis is a commensal organism, it can be considered an 
opportunistic pathogen causing infections via catheters and medical devices 66. S. 
pyogenes, a human pathogen, is a Gram-positive cocci (0.6-1 µm) that colonizes the 
nasopharynx and the skin at portals of entry or as asymptomatic carriers 60.  Streptococci 
species are common on the skin and in the upper respiratory system. Group A 
Streptococcus can be classified by their beta-hemolytic behavior on blood agar. 
Streptococci are transmitted by contact between humans who carry the organism or have 
an associated disease. When disease occurs, the organism grows on mucous membranes, 
in skin, or in deep tissues.  M. luteus is a Gram-positive cocci (0.6-1 µm) that is a normal 
inhabitant of human skin. This microbe rarely causes infections; however, M. luteus has 
been associated with septic arthritis, meningitis, and endocarditis in patients with immune 
suppressive conditions 76. E. faecalis is a Gram-positive cocci (0.5-1 µm) that grows in 
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pairs or chains and ferments carbon sources that produce lactic acid 60. Enterococci are 
commensal organisms that survive in intestinal and vaginal tracts and the oral cavity 45. 
E. faecalis causes 80-90% of infection of Enterococci infections and is the fourth leading 
cause of hospital-acquired infections and the third leading cause of bacteremia in the 
United States 24,45. Enterococci are frequently isolated with Staphylococci in diabetic soft 
tissue infections, which is the reason for the use of this species as a negative control 39.   
Other potential contaminants that were utilized to recapitulate samples that may 
be found in a Staphylococcal food-poisoning sample were: Escherichia coli, 
Enterobacter aerogenes, and Listeria monocytogenes. Bacillus subtilis was also utilized 
as a potential environmental contaminant.  E. coli is a flagellated Gram-negative rod (2 
µm in length) found living in the intestines of people and animals. Pathogenic E. coli 
strains can cause urinary tract infections, respiratory illness and pneumonia, and other 
gastrointestinal illnesses. E. coli is generally transmitted through contaminated water or 
food, or via direct contact with animals or humans 13.  E. aerogenes is a Gram-negative 
(1.2-3.0 µm in length) flagellated rod shaped organism found in soil, water, dairy 
products, and in the intestines of humans and animals. E. faecalis is a Gram-positive 
cocci (0.5-1 µm) that is an opportunistic pathogen that generally infects 
immunocompromised individuals and causes urinary tract infections, endocarditis, 
abdominal infections, and septic arthritis 81.  L. monocytogenes is a Gram-positive rod 
shaped (2 µm) bacteria with a temperature regulated flagella 35. L. monocytogenes causes 
serious infections by eating food contaminated with this microbe. Symptoms of listeriosis 
include fever and muscle aches, sometimes diarrhea and other gastrointestinal symptoms 
12. B. subtilis is an endospore forming Gram-positive rod (3 µm in length) that is typically 
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found in soil, dust, water, and in the air; however, its primary reservoir is soil 80. Bacillus 
species are organisms that are common residents of dirt, soil, and dust and therefore 
could be co-isolated with S. aureus in samples contaminated with dirt, soil, and/or dust.   
  
Table 1. Staphylococcus aureus Protein A protein BLAST results. S. aureus Protein A protein 
sequence was obtained using NCBI a BLAST search was conducted, excluding S. aureus (taxid: 
1280), synthetic constructs (taxid: 32630), plasmids (taxid: 36549), and cloning vectors (taxid: 
29278) in order to determine what other organisms had a protein similar in percent identity to S. 
aureus Protein A. 
Description Strain 
Max 
Score 
Total 
Score 
Query 
Cover 
E-
Value 
Percent 
Identity 
Accession 
 
Immunoglobulin G  
Binding Protein A 
 
Staphylococcus 
argenteus 
578 578 99% 0 95% CDR59589.1 
Protein A 
Staphylococcus 
schweitzeri 
528 1006 99% 0 79% CDR66424.1 
Hypothetical protein 
Staphylococcus 
hyicus 
333 333 87% 
2.00E
-108 
64% 
WP_03964360
2.1 
Peptidoglycan-
binding protein LysM 
Staphylococcus 
pseudintermedi
us 
333 333 99% 
9.00E
-108 
60% 
WP_03754204
7.1 
Immunoglobulin G 
binding Protein A 
Staphylococcus 
schleiferi 
328 644 97% 
3.00E
-104 
68% BAS44959.1 
Hypothetical protein 
Staphylococcus 
intermedius 
252 252 68% 
2.00E
-77 
61% 
WP_01916745
5.1 
Immunoglobulin G-
binding Protein A 
Staphylococcus 
sp. HGB0015 
246 403 86% 
1.00E
-76 
62% EPD49293.1 
Immunoglobulin G-
binding Protein A 
spa2 
Staphylococcus 
pseudintermedi
us 
243 243 95% 
8.00E
-74 
50% 
WP_01461269
8.1 
Hypothetical protein 
Staphylococcus 
simulans 
100 100 70% 
2.00E
-20 
34% 
WP_05751004
9.1 
BBM3XM 
Staphylococcus 
xylosus 
90.9 320 30% 
8.00E
-17 
90% AAA26599.1 
PPmABPXM 
precursor 
Staphylococcus 
carnosus 
79.7 200 17% 
4.00E
-13 
80% AAA61965.1 
Hypothetical protein 
Staphylococcus 
delphini 
75.9 194 84% 
6.00E
-12 
33% 
WP_01916601
9.1 
Hypothetical protein 
Staphylococcus 
condimenti 
65.9 65.9 38% 
2.00E
-08 
36% 
WP_04713280
8.1 
Hypothetical protein 
Staphylococcus 
chromogenes 
61.6 183 84% 
4.00E
-07 
31% 
WP_03757738
1.1 
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In addition to the previously mentioned negative controls, another subset of negative 
controls utilized in this study included organisms that possess Protein A on its surface. A 
protein BLAST search revealed strains with similar identity to Protein A (Table 1). The 
bacterial strains found to have a percent identity greater than 30% were included in Table 
1. All of the bacterial strains found to have a percent identity greater than 30% were 
Staphylococci species. Of these subspecies, Staphylococcus argenteus and 
Staphylococcus schweitzer have been found to be phenotypically similar to S. aureus.  S. 
argenteus is a non-pigmented human isolated strain that is nucA positive; while S. 
schweitzer is a non-human primate strain that is nucA negative. nucA is a virulence 
associated gene that codes for thermostable nuclease which plays a role in the evasion of 
neutrophil extracellular traps 48,82. Although S. argenteus and S. schweitzer are the closest 
known relatives of S. aureus, S. argenteus has only rarely been recovered from humans 
hosts and S. schweitzer has only been recovered from a human host once to date 84. 
Staphylococcus intermedius, Staphylococcus pseudointermedius, and Stpahylococcus 
delphini are zoonotic strains that are typically colonizers of animals including dogs, cats, 
and pigeons. These strains have typically been associated with infections caused by 
animal bites but rarely colonize humans 87.  Staphylococcus simulans has been isolated 
from a number of animals and humans and it is also the most frequently isolated species 
in association with bovine mastitis 1. Of the strains mentioned in Table 1, S. intermedius 
and S. simulans were used in this study. 
Rapid bacterial identification by laser-light scattering 
Previous studies suggest that particle size, shape, density, and motion can all 
influence how a particular particle scatters light 6,62. Bacterial cells can be thought of as 
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small particles, and different 
species have specific shapes, sizes, 
and internal characteristics that 
cause them to scatter laser-light 
into distinctive patterns 6,37. To 
understand how a specific species 
of bacteria (like S. aureus) scatters 
laser-light, many thousands of 
individual cells of a species of 
interest are measured in a device 
developed by Micro Identification Technologies (MIT, located in San Clemente, CA; 
www.micro-imaging.com). MIT has developed a system for rapid laser based microbial 
detection and identification. This system measures laser-light scattering intensity as 
individual microbes pass through a laser beam. The light scattering pattern is influenced 
by the size, shape, external and internal optical characteristics, and the motility of the 
microbe. The system can detect and differentiate the size of bacteria by measuring the 
scattering light at specific angles. The system can detect and differentiate objects within a 
range of sizes from 0.5 µm to more than 10 µm, which is the typical size range for most 
bacteria.  MIT uses an empirically based “Statistical Classification Algorithm” and a set 
of pre-measured microbial scattering characteristics called Identifiers. The Identifiers are 
generated from light scattering measurements of thousands of individual cells of known 
microbial species or subspecies. The individual cells of specific microbes are analyzed to 
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identify the measured characteristics that best differentiate that species from another, or 
subspecies from another.  
The MIT system feeds a stream of 
light scatter measurements into the Statistical 
Classification Algorithm to determine if the 
measured cells are members of a specific 
Identifier within the MIT database. For 
example, when using the Staphylococcus spp. 
Identifier, the system determines if the 
sample is or is not Staphylococcus spp. The 
system has the ability to feed the same light 
scatter measurements into multiple 
Identifiers simultaneously. Consequently, 
the system can determine if the sample statistically matches any Identifier in the MIT 
database.   
The MIT system consists of five concentric arcs of photodetectors that are located 
at a variety of positions along the surrounding arcs (Figure 1). Each photodetector is 
positioned to view through the arcs to the center-of-curvature of the arcs 37. A solid-state 
laser (660 nM) passes through the same center-of-curvature where a round bottom flask 
containing a sample is positioned. As the laser passes through the sample, particles pass 
through the laser beam resulting in scattered light. Photodetectors record and measure the 
particles passing through the laser beam. A photon of light striking the photodetector 
generates a voltage. The MIT system identifies bacteria by analyzing laser-light scatter of 
Figure 2. Light scattering intensity as a 
microbe passes though the laser beam. 
The laser beam is directed toward the 
reader. 
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individual bacterial cells suspended in filtered water. When the laser contacts a particle 
within a sample, the light both reflects off the outer surface and penetrates the body of the 
particle, interacting with structural features that are specific to that particle.  As a microbe 
passes through the laser beam, the intensity of the scattered light increases as it gets 
closer to the center of the beam and decreases as it leaves the beam. The scattered light 
measured by the surrounding detectors produces a signal similar to that shown in Figure 
2.  A single particle that has passed through the laser beam is called an event. Figure 3 
displays a typical single particle event measured as a signal (voltage) over time. More 
specifically, Figure 3 displays the measured scattered light intensity for two 1.5 µm 
diameter polystyrene latex spheres (Figure 3A) and two individual S. epidermidis cells 
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(Figure 3B) versus time. The colored curves are the measured signal from all detectors on 
one arc in the MIT system. The signal measured by the detectors is influenced by size, 
shape, external and internal optical characteristics and where in the beam the particle is 
located. In Figure 3, the difference between the polystyrene latex sphere and S. 
epidermidis is apparent; displaying that the individual cells of S. epidermidis are not 
spherically symmetrical thus resulting in variations to its scattering pattern.    
By measuring hundreds of thousands of events for a specific bacterial species, the 
average scattered light pattern for that particular species of interest becomes apparent 
through statistical analysis. As mentioned previously, MIT has developed a Statistical 
Classification Algorithm that classifies the sources of events. When bacteria cause the 
events, the classification is an identification of the bacterial species. The Statistical 
Classification Algorithm uses a collection of distributions called Judges that are merged 
Probability Densities constructed from known pre-measured bacterial species and further 
organized into entities called Identifiers. The Identifier contains Probability Densities 
derived from measured events. A large number of events for each species are required in 
Figure 4. Frequency-of-Occurrence Histogram for 1.5 µm diameter polystyrene spheres. This 
Frequency-of-Occurrence histogram is an example for 1.5 µm diameter polystyrene spheres.  
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order to ensure that the derived Probability Densities are representative of the species 
involved. The same analysis may be applied to any variation in dimensions. This process 
begins by defining an Observable. An Observable is one or more values calculated from 
specified measured quantities. Figure 3A displays an instant in time in the left event 
indicated by the gold colored vertical line labeled c This is the instant in time defined as 
the time that the detector plotted in the same gold color attains a maximum for this event. 
Looking closely at two detectors in Figure 3A, detector A in purple and detector B in 
green at the instant marked by the vertical line c. In the left event, the two detectors have 
a value of a and b at instant c. This results in Observable C(a,b). Values for each 
Observable can be calculated from any other measurement. Each measurement produces 
slightly different values for a and b. For the same sample (polystyrene latex spheres in 
this case), slightly different Observable values measured by measuring many thousands 
of different samples.  
Figure 5. Frequency-of-Occurrence Histogram for Staphylococcus epidermidis. This 
Frequency-of-Occurrence histogram is an example for S. epidermidis using the same 
Observable and plotted on the same scale as figure 4. 
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Figure 4 shows a Frequency-of-Occurrence 
histogram and its contour for the Observable C(a,b). 
This plots the number of times a pair of values, a 
(x-axis) and b (y-axis) is measured simultaneously 
by the detectors A and B for thousands of individual 
spheres. When normalized so that the volume of the 
histogram is 1.0, the histogram can be interpreted as 
a Probability Distribution, which gives the 
probability that a range of signals measured by 
detectors A and B are simultaneously measured for the sphere. Figure 3B displays two 
typical events of individual cells of S. epidermidis and the same Observable illustrated in 
Figure 3A. Figure 5 displays the Frequency-of-Occurrence Histogram and its contour for 
S. epidermidis using the same Observable C(a,b) used to create Figure 4.  The scale and 
the axis limits are the same in both Figure 4 and 5. Since the scales and limits are the 
same, superposing one of the contours over the other allows direct comparison of the 
contours which is displayed in Figure 6. There is no overlap between the contours in 
Figure 6. The Frequency-of-Occurrence histograms therefore display that the size, shape, 
and location of the contours show a species dependence.  
An Observable and the Probability Distribution curves generated from measurements 
using that Observable for a group of species like in Figure 7 is a Judge. The Judge has 
one Probability Distribution curve for each species and provides an opinion on the 
identification of measurements of unknown particles. The Judge’s Opinion is the 
likelihood that the cell is a particular species. The MIT system utilizes a Panel of Judges 
Figure 6. Superposition of the 
contours of the Frequency-of-
Occurrence Histograms in 
figure 4 and 5.  
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in order to determine the identification Opinion for that unknown sample. Combining the 
Opinions of individual Judges using standard probability and statistical methods allows 
for a stronger Opinion compared to that of a single Judge’s Opinion. Figure 8 displays a 
series of Judges, each with different Observables and each column is a Judge consisting 
of Probability Density contours derived from its Observable.  Judge 1 is the Observable 
F(d,e), or the values of detectors D and E when detector F is a maximum. Judge 2 is the 
Observable I(g,h), or the values of detectors G and H when detector I is a maximum. The 
axis limits and scale of the contours in each column are the same. This grouping of 
Judges is referred to as a Panel of Judges.  
A Panel of Judges does not always return a definitive identification and additional 
discrimination information is still needed.  The Identification process using MIT 
Figure 7. Contours of other bacterial species. These contours are for the same Observable and 
on the same scale as shown in figures 4 and 5. The crosshair is located at the same coordinate 
in each plot, this is a Judge. 
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technology is significantly enhanced when multiple cells of the same unknown species 
are measured in one sample. After measuring the first bacterial cell, the Panel of Judges 
use event data to produce an identification Opinion of the unknown species.  
 
The Opinion takes the form of a series of identification probabilities, which are combined 
as the Total Identification Probability. As more cells are measured and processed, the 
Total Identification Probability for the unknown species then get closer to one. If the 
probability of one species is greater than 0.999 five times in a row, the species then 
identifies.  
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The Panel of Judges provides quick and accurate identification of any of the species 
found in the MIT database. This process is closed, meaning, if the unknown sample is not 
one of the species handled by the Panel of Judges the result is unpredictable. MIT has 
developed an open equivalent to the Panel of Judges called an Identifier. The Identifier 
then determines whether the stream of cells is one of the species  
within its database or if the result is “Unknown.” For example, a Listeria species 
Identifier determines whether the stream of cells is Listeria species or if it is Unknown. 
The system can simultaneously run tests for all of its Identifiers within its database, those 
including Listeria species, Staphylococcus species, and S. aureus. Figure 9 displays the 
simultaneous identification process utilizing two Identifiers, Listeria species and 
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Staphylococcus species. The identification tests take roughly 30 seconds to 5 minutes 
with the average test being 2 minutes. In order for this test to be successfully conducted, 
the system requires 10 to about 40 cells to complete depending on the rate the cells are 
being measured at.  
MIT sample preparation is simple, requires only a few minutes, and is the same 
for all species. The supplies and apparatus that are required are: 1 inoculating loop, 1 
microcentrifuge tube, 1 pipette tip, a vortex mixer, a 0.5-10 µL adjustable pipette, a MIT 
sample vial, and a 1” x 1” square of parafilm.  The sample preparation procedure goes as 
follows: (1) remove a colony from a culture plate using a sterile loop, (2) dislodge the 
bacterial colony into a microcentrifuge tube containing filtered water, (3) vigorously 
agitate the microcentrifuge tube by vortexing the bacterial cells, and (4) inoculate an MIT 
sample vial with approximately 1 µL of the bacterial suspension. After placing the 
inoculated vial into the MIT system, click “Identify” on the MIT interface program. The 
total time until identification using the MIT system totals approximately 5 minutes.  
The majority of rapid bacterial identification technologies are designed to detect 
the presence of genetic material or proteins from a pathogen in a patient specimen. 
Detection of genomic material can be both highly sensitive and accurate, however these 
methods may have limitations. Mass spectrometry and antibody-based tests that detect 
pathogen proteins may require expensive machines, chemical reagents, and/or highly 
skilled sample processing. Many of these tests have turnaround times as long as 18 to 48 
hours. Therefore, a rapid bacterial detection system that is sensitive, accurate, and cost 
effective would be advantageous.  MIT technology is extremely easy to use and reduces 
time, effort and cost resulting in microbial identification. The system does not rely on 
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chemical processing, fluorescent tags or DNA analysis. The system eliminates elaborate 
and lengthy sample preparation required in other identification techniques. The same 1 
minute sample preparation is held consistent for every test run in the system. The system 
requires no other additional chemicals, reagents or processing procedures, other than 
dilutions. The MIT system identifies all characterized species without reconfiguration 
using the same procedure. Finally, the amount of supplies and inventory required for 
identification are reduced drastically compared to other identification methods.  MIT has 
developed their system to detect Listeria species (food-borne pathogens) from food 
samples. Independent laboratories have verified that the MIT system identifies Listeria 
species with greater than 90% accuracy. The MIT system was awarded Association of 
Analytical Communities Research Institute Performance Tested Methods (AOAC RI 
PTM) certification for its Listeria species Identifier. MIT is working to exapnd the list of 
Identifiers. Staphylococcus species Identifier was utilized for this project. A S. aureus 
Identifier is nearing completion, but was not available at the time of this study. 
Rapid bacteria capture by ImmunoMagnetic separation (IMS) 
 
Before this study, the MIT 1000 was being used to identify bacteria from colonies 
grown on agar plates. The process of growing bacteria colonies can typically take 12-48 
hours before the bacteria can be analyzed by laser-light scattering (which takes less than 
5 minutes).  IMS could potentially capture bacteria cells for laser-light scattering 
identification within a few hours. IMS is a rapid isolation method that captures proteins 
or cells using a magnetic field. Magnetic beads (10 mg/ml) are coated with antibodies 
(2.8 µm, 1 mg/ml) specific for surface antigens of the desired cells 74.  The two 
components of the IMS method are Streptavidin coated magnetic beads (DynaBeads) and 
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biotinylated S. aureus antibodies (Figure 10). The biotinylated S. aureus antibodies can 
be linked to Streptavidin on the surface of the DynaBeads due to Streptavidin’s extremely 
high binding affinity for biotin (Kd = 10
-14 to -15 M) 5,43. When the conjugated magnetic 
beads and antibodies are exposed to a mixed cell population, the magnetic beads attach to 
the surface of the desired cells via antibody-antigen interaction. The desired cells can 
then be separated by a strong magnetic field 74. In this study, we are utilizing a protein 
found specifically on the surface of S. aureus, called Protein A, as the receptor for 
antibody binding 17.  
 
Protein A, a 42-kDa conserved surface protein of S. aureus is composed of three 
different regions: the S region, which is the signal sequence processed during secretion, 
five highly homologous extracellular Ig-binding domains found in tandem and designated 
as E, D, A, B, and C, and a cell-wall anchoring region XM 33,42. Each of the five domains 
are arranged in an anti-parallel alpha-helical bundle of approximately 58 amino acids. 
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This structure is stabilized by a hydrophobic core 42. Each of these five regions has the 
ability to independently bind the Fc or Fab region of IgG antibodies 22,33,42,57. The Fc 
binding site has shown to involve 11 residues of helix 1 and 2 22. The Fab binding region 
is located separately from the Fc binding region, the Fab binding site involves 11 residues 
located on helix 2 and 3 33. Commercial antibodies against Protein A are available that 
have biotin conjugated to the Fc region. 
Streptavidin (52.8-kDa), isolated from Streptomyces avidinii, is a tetrameric 
protein that can bind up to four d-biotin molecules with extremely high affinity 77. The 
ability of streptavidin to bind biotin has led to widespread use in diagnostic assays that 
require near-irreversible and specific linkage 88. Streptavidin subunits are organized as 
eight-stranded, connected, anti-parallel beta sheets. This arrangement produces a 
cyclically hydrogen-bonded barrel with several extended hairpin loops. One of the 
extended hairpin loops is located near the carboxyl terminus where it is free to form an 
extended beta sheet 88. The pairs of streptavidin barrels hydrogen bonded together form 
symmetric dimers. Streptavidin forms a tetramer by pairing two dimers, the tetramer is 
stabilized by Van der Waals interactions between the surfaces of the beta barrels 88. 
Biotin then binds in the pockets at the ends of each of the streptavidin beta barrels. Biotin 
binding involves the removal of bound water molecules that occupy the binding site. 
After the removal of water, multiple interactions between biotin heteroatoms and the 
binding site residues of streptavidin allow for the burial of biotin by way of a surface loop 
of streptavidin 88. The strength of the streptavidin-biotin bond is the consequence of an 
expansive number of interactions, which results in a near-irreversible bond that can be 
exploited for diagnostic assays and other molecular uses.  
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The use of IMS for bacterial isolation in food samples has been shown to be more 
efficient than conventional centrifugation and other filtration methods 74. IMS has the 
potential to separate S. aureus from a sample in 4-8 hours and MIT laser-light scattering 
technology could complete identification in 5 minutes. It has been shown that live S. 
aureus cells can be isolated using S. aureus antibodies bound to magnetic beads, which 
establishes IMS technology as a method of S. aureus bacterial isolation 18.   
With this technique in mind, this study aims to (1) develop IMS to magnetically 
capture cells of S. aureus using anti-Protein A antibodies and (2) develop IMS to 
specifically capture and identify cells of S. aureus from swab specimens. The success of 
this combination could allow for the accurate diagnosis of S. aureus infection in 4-8 
hours, as opposed to traditional culture based methods which take up to 24-48 hours. 
Developing these methods for rapid capture and identification of S. aureus could lead to 
improve patient outcomes by resulting in faster treatment administration.   
In addition, my thesis seeks to answer the following questions: 1) can S. aureus be 
identified from solid agar plates by laser-light scattering analysis, 2) can S. aureus be 
specifically separated from samples using IMS and 3) in combination with IMS, can 
laser-light scattering analysis increase the speed and accuracy of S. aureus identification? 
Our goal is to determine if the combination of IMS and laser-light identification can 
accurately identify S. aureus in swab samples while decreasing the total identification 
time to 4-8 hours. We hypothesized that anti-Protein A conjugated magnetic DynaBeads 
(also referred to as, anti-Protein A DynaBeads) would bind to surface Protein A on S. 
aureus in a swab sample and facilitate their isolation upon exposure to a magnetic field 
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within a 4-8 hour procedure. S. aureus cells isolated by IMS can then be accurately 
identified using MIT technology in less than 5 minutes.  
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CHAPTER TWO: SINGLE LASER-LIGHT SCATTERING 
 
 
 
 
INTRODUCTION 
 
Laser-light scattering technology developed by MIT measures laser-light 
scattering intensity as individual microbes pass through a laser beam. The light scattering 
pattern is influenced by the size, shape, external and internal optical characteristics, and 
the motility of the microbe. In order to identify microbes via laser-light scattering, the 
bacteria must first be grown on agar plates. Due to the possibility that different bacteria 
growth media types may influence bacteria cell size and shape, we needed to determine if 
the accuracy of bacterial identification was dependent on the growth media that the 
bacteria was grown on. To test this, four common types of growth media were used to 
evaluate if the media type influenced the laser-light scattering patterns and identification 
accuracy of the MIT 1000. To perform this analysis, 10 Staphylococcus species and 6 
negative control strains were tested a minimum of 10 times in the MIT 1000. Percent 
identified as Staphylococcus species was calculated for each growth media type.  
 The identification technology developed by MIT was generated by measuring 
thousands of laser-light scattering measurements of known bacterial strains in order to 
develop an Identifier specific to that bacteria. Previous studies have shown that 
laboratory and clinically isolated strains can differ in size and shape despite being the 
same species 71. With this in mind, we needed to assess the accuracy of the device from 
both laboratory and clinical strains. To further assess the accuracy of MIT 1000 bacterial 
identification technology, a single blind study was conducted using clinical isolates 
obtained from UP Health System-Marquette. In total, 90 clinical isolates were obtained 
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from UP Health System-Marquette on blood plates. The identity of the bacteria isolates 
was not revealed to our lab until all identification tests with the MIT 1000 were 
completed. Each clinical isolate was identified using the MIT instrument and 
identifications were conducted a minimum of 3 times for each strain.  Percent identified 
as Staphylococcus species was calculated and MIT identifications were compared to 
hospital determined identifications.  
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METHODS 
 
 
 
 
Bacterial strains and culture conditions 
 
S. aureus 6538 (ATCC) was used as the positive control in all experiments 
conducted during this project. S. aureus 6538 has a history of use in quality control 
testing, food testing, and other laboratory applications 79. This strain was initially isolated 
from a human lesion. Other strains that were utilized in this study are displayed in Table 
2.  All bacterial strains were grown in tryptic soy broth (TSB, Hardy Diagnostics) at 37 ͦ C 
for 18 hours in aerobic conditions with the exception of S. pyogenes which was grown in 
reduced oxygen conditions (candle jars). Bacterial cultures were grown in liquid TSB 
media shaken at 200 rpm and incubated at 37 ͦ C for 18 hours.  
Table 2. Bacterial strains used in this study. Bacterial strains and strain source are listed. 
Bacteria Strain Source 
Bacillus subtilis 11774 ATCC 
Enterobacter aerogenes 35029 ATCC 
Enterococcus faecalis 7080 ATCC 
Escherichia coli 29543 ATCC 
Listeria monocytogenes 19115 ATCC 
Micrococcus luteus SK58 BEI Resources 
Serratia marcescens 14756 ATCC 
Staphylococcus aureus 25923 ATCC 
Staphylococcus aureus 29213 ATCC 
Staphylococcus aureus 6538 ATCC 
Staphylococcus aureus F003B2N-C BEI Resources 
Staphylococcus aureus HI022 BEI Resources 
Staphylococcus epidermidis 35983 ATCC 
Staphylococcus epidermidis 49134 ATCC 
Staphylococcus epidermidis 49461 ATCC 
Staphylococcus epidermidis SK135 BEI Resources 
Staphylococcus intermedius 29663 ATCC 
Staphylococcus simulans (Clinical isolate) UP Health System- Marquette 
Streptococcus agalactiae MNZ933 BEI Resources 
Streptococcus pyogenes MGAS 1882 BEI Resources 
Streptococcus salivarius SK126 BEI Resources 
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Rapid MIT identification from agar colonies 
MIT identification procedure from agar plates 
 
Colonies were removed from an agar plate using a sterile loop. The bacteria 
collected on the loop were dislodged into a microcentrifuge tube that contained about 200 
µl of filtered water (3 stage water filter by Watts (North Andover, MA), three stages of 
filtration (1) sediment, (2) pre-carbon, and (3) VF, 0.6 µm membrane). The 
microcentrifuge tubes were vigorously agitated by vortexing (20-30 seconds) to 
dissociate the bacterial cells. The MIT sample vial were inoculated (15 ml round bottom 
flask, VWR) with about 1 µl of the bacterial suspension. The top of the vial was covered 
with parafilm (VWR). The MIT sample vial was then secured with parafilm by a rubber 
band (VWR) and the vial was tipped to resuspend the bacteria. Sample preparation was 
the same for all species of bacteria. The prepared sample was then placed into the MIT 
system (MIT 1000). To run the MIT 1000, the User selects the “Identify” button on the 
MIT Interface Program. The program runs the test and the result was displayed within 2-
5 minutes.  
Laser-light scattering analysis of bacteria grown on solid media  
 
In order to determine if accuracy of bacteria identification was dependent on the 
type of growth media used to culture the organisms, the accuracy of the laser-scattering 
technology was challenged by growing known bacteria strains on 4 different solid media. 
Various Staphylococcus species and negative controls were grown on different medium 
in order to determine if the type of growth media effected the accuracy of identification. 
Media utilized in this analysis were common laboratory media: blood agar (Hardy 
Diagnostics), brain heart infusion agar (BHI, Hardy Diagnostics), lysogeny broth (LB, 
Hardy Diagnostics), and tryptic soy broth (TSB, Hardy Diagnostics). Strains utilized in 
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this analysis: S. aureus 25923, S. aureus HI022, S. aureus 29213, S. aureus 6538, S. 
aureus F003B2NL, S. epidermidis 49461, S. epidermidis 49134, S. epidermidis 35983, S. 
epidermidis SK135, S. intermedius 29663, S. pyogenes MGAS 1882, Streptococcus 
agalactiae MNZ 933, Streptococcus salivarius SK126, and M. luteus SK58. Each strain 
was tested in the MIT 1000 a minimum of 10 times for each media using MIT 
identification procedure from agar plates protocol.  
Rapid MIT identification from clinical specimens obtained by UP Health System 
Marquette: A single blind study (Appendix A, approval to use clinical specimens from 
UP Health System Marquette) 
 
Clinically isolated strains of bacteria can differ significantly from laboratory 
adapted strains. A single blind study was conducted using bacteria isolated from clinical 
samples. This single blind study was conducted to evaluate the MIT 1000’s ability to 
identify bacteria from real patient samples rather than laboratory strains. The identities of 
the bacteria samples were known by UP Health System- Marquette and unknown to our 
laboratory. In total, 90 clinical isolates were obtained from UP Health System on blood 
agar plates. Colonies from these 90 clinical isolates were measured a minimum of 3 times 
in the MIT instrument to determine the accuracy of identification of clinical strains of 
bacteria. The set of clinical isolates sent to our laboratory included Staphylococcus 
species as well as a subset of unknown negative controls. All samples were tested using 
the MIT identification procedure from colonies on agar plates mentioned above. After all 
identification measurements were made, our results were compared to the known 
identifications made by the UP Health Systems Microbiology Laboratories. The succesful 
identification of all clinically isolated Staphylococcus strains was proof of concept that 
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light-scattering technology could identify laboratory strans as well as clinical isolates of 
Staphylococcus species. 
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RESULTS 
 
 
 
 
Analysis of MIT identification of bacteria grown on different media  
 
In order to determine if the accuracy of bacteria identification was dependent on 
the type of growth media used to culture the organisms, organisms were grown on four 
different commercially available agar plates and tested using the MIT 1000. Ten 
Staphylococcus species were used as positive controls and 6 negative controls strains 
were also utilized. Each strain was tested in the MIT 1000 a minimum of 10 times and the 
percent identified as Staphylococcus species was calculated.  
The average percent identified as Staphylococcus species using the MIT 1000 of 
the 10 Staphylococcus strains on blood agar was 97.3% + 3.59 ; while the 6 negative 
controls strains had an average of 3% + 2.45 miss-identified as Staphylococcus species.  
The average percent identified as Staphylococcus species of the 10 Staphylococcus 
strains on BHI agar was 97.0% + 4.22 ; while the 6 negative controls strains had an 
average of 0.83% + 2.04 miss-identified as Staphylococcus species.  The average percent 
identified as Staphylococcus species of the 10 Staphylococcus strains on LB agar was 
96.4% + 3.89; while the 6 negative controls strains had an average of 0.83% + 2.04 miss-
identified as Staphylococcus species.  The average percent identified as Staphylococcus 
species of the 10 Staphylococcus strains on TSB agar was 97.1% + 3.96 ; while the 6 
negative controls strains had an average of 0% + 0.00 miss-identified as Staphylococcus 
species.  Overall, greater than 95.00% of the positive Staphylococcus species identified as 
Staphylococcus species using the MIT 1000 and less than 5.00% of the non-
Staphylococcus negative controls miss-identified as Staphylococcus species. This 
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displays that bacterial identification by the MIT 1000 is not dependent upon growth 
media. 
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Figure 11. Percent identified as Staphylococcus species grown on blood agar. Positive 
Staphylococcus species identified as Staphylococcus species using the MIT 1000 an average 
of 97.3% + 3.59. The false positive rate of non-Staphylococcus species miss-identified as 
Staphylococcus species using the MIT 1000 an average of 3% + 2.45.  
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Figure 12. Percent identified as Staphylococcus species grown on BHI agar. Positive 
Staphylococcus species identified as Staphylococcus species using the MIT 1000 an average 
of 97.0% + 4.22. The false positive rate of non-Staphylococcus species miss-identified as 
Staphylococcus species using the MIT 1000 an average of 0.83% + 2.04.  
 
Figure 13. Percent identified as Staphylococcus species grown on LB agar. Positive 
Staphylococcus species identified as Staphylococcus species using the MIT 1000 an average 
of 96.4% + 3.89. The false positive rate of non-Staphylococcus species miss-identified as 
Staphylococcus species using the MIT 1000 an average of 0.83% + 2.04. 
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Single blind study- MIT identification from clinical specimens 
 
In total, our lab obtained 90 clinical isolates on blood plates from UP Health 
System Marquette. Our lab obtained 30 isolates in a month’s duration. The isolates were 
supplied on blood agar, and only a number as an identifier. The hospital-determined 
identity of the bacteria isolates were not revealed to our laboratory until we finished all of 
the identification tests with the MIT 1000. Each strain was identified using the MIT 
instrument and identifications were conducted a minimum of 3 times for each strain. In 
this single blind study 100% of the Staphylococcus species sent to us by the hospital were 
correctly identified by the MIT instrument (Table 3). In addition, there were no false-
positive results. None of the non-Staphylococcus bacteria misidentified as 
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Figure 14. Percent identified as Staphylococcus species grown on TSB agar. Positive 
Staphylococcus species identified as Staphylococcus species using the MIT 1000 an average 
of 97.1% + 3.96. The false positive rate of non -Staphylococcus species miss-identified as 
Staphylococcus species using the MIT 1000 an average of 0.00% + 0.00. 
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Staphylococcus species, which provides evidence of the MIT instrument’s accuracy on 
both laboratory and real patient samples.  
 
Table 3.  Results of a single blind study.  A total of 90 de-identified bacterial 
isolates were submitted to NMU for identification with the MIT 1000.  Each strain 
isolate was measured at least 3 times in the MIT 1000.  Staphylococcus species are 
highlighted in yellow.  Other Gram positive cocci are in red.  Gram negative cocci 
are in blue. 
Hospital clinical isolates 
De-identified hospital 
isolates tested in the MIT 
1000 
MIT 1000 identified as 
Staph. spp. 
Corynebacterium 
diphtheriae 
1 0 
Corynebacterium spp. 1 0 
Enterobacter cloacae 1 0 
Enterococcus faecalis 13 0 
Enterococcus faecium 1 0 
Enterococcus spp. 2 0 
Escherichia coli 14 0 
Klebsiella pneumoniae 5 0 
Methicillin Resistant S. 
aureus 
8 8 
Neisseria spp. 1 0 
Proteus mirabilis 4 0 
Providencia rettgeri 1 0 
Pseudomonas aeruginosa 2 0 
Staphylococcus aureus 16 16 
Staphylococcus 
epidermidis 
4 4 
Staphylococcus simulans 1 1 
Staphylococcus spp. 
(Coagulase negative) 
1 1 
Streptococcus group A 4 0 
Streptococcus group B 4 0 
Streptococcus group C 1 0 
Streptococcus group D 
(not Enterococcus spp.) 
1 0 
Streptococcus 
pneumoniae 
1 0 
Viridans streptococci 3 0 
Totals: 90 30 
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DISCUSSION 
 
 
 
 
Staphylococcus aureus is the most commonly isolated human associated bacterial 
pathogen. It plays an important role in skin and soft-tissue infections, pneumonia, 
endocarditis, osteomyelitis, foreign-body infections, and sepsis 21,69. S. aureus is typically 
identified by coagulase tests or latex agglutination tests; however, identification can also 
be achieved by detection of Protein A production and heat-stable nuclease 8. Molecular 
based tests, such as PCR are conducted by way of S. aureus-specific genetic targets. The 
time until diagnosis of S. aureus infections can range from 24-48 hours depending upon 
the identification method 10. With this in mind, it has been shown that faster pathogen 
identification has been linked to improved patient outcome 49. The impact of faster 
identification on patient outcome has led us to test alternative methods of S. aureus 
identification. As an alternative to traditional bacteria identification, single cell laser-light 
scattering technology (MIT 1000 instrument) was utilized as a form of rapid 
identification of S. aureus. In as little as 5 minutes, this technology identifies a pure 
bacteria sample by comparing laser-light scattering patterns to known scattering patterns 
(Identifier) in its database. MIT has received AOAC certification for their Listeria 
species Identifier and will soon receive certification for their Staphylococcus species 
Identifier.  
In this section, we addressed the following questions: does the growth media that 
the bacteria is grown with effect the accuracy of identification and can S. aureus be 
identified by single cell laser-light scattering technology and, if so, how accurately? We 
also asked the question, can laser-light scattering technology identify laboratory strains 
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and clinical isolates with the same rate of accuracy? To evaluate the effect of growth 
media on MIT 1000 identification and the accuracy of identification of laboratory strains, 
10 Staphylococcus species and 6 non-Staphylococcus negative control species were tested 
in 4 different types of common media types (Figures 11-14). Based on the media 
analysis, we determined that the type of media does not significantly affect the accuracy 
of MIT 1000 identification on either positive or negative control strains. TSB agar 
performed the best when considering false positive results, displaying 0.00% + 0.00 of 
the negative controls miss-identifying as Staphylococcus species. Considering these 
results, we chose to perform further experiments with TSB media. TSB media also has 
common overlapping ingredients including: sodium chloride, dextrose, and soybean meal 
with LB, BHI, and blood agar which further supports our decision to utilize TSB as our 
main media type.  
Previous studies have highlighted significant differences in the genomes of 
laboratory strains and clinical isolates, which may lead to phenotypic changes to the 
microbes physical structure 71. Due to the importance of cell size and shape in laser-light 
scattering identification, and the knowledge that laboratory and clinical isolates differ, 
both laboratory and clinical isolates were utilized in the testing of laser-light scattering 
identification accuracy. A single blind study was conducted in order to address the 
question, can laser-light scattering technology identify laboratory strains and clinical 
isolates with the same rate of accuracy. We performed a single blind study in 
collaboration with UP Health System- Marquette, which included a total of 90 de-
identified bacterial isolates. Each of these clinical isolates were identified a minimum of 
3 times with the MIT 1000. The provided clinical isolates not only included various 
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strains of Staphylococcus species (MRSA, S. aureus, S. epidermidis, and S. simulans), 
but also included Gram positive and negative cocci and rods. Of the 30 Staphylococcus 
clinical strains, all 30 accurately identified as Staphylococcus species using laser-light 
scattering technology. In addition, the remaining non-Staphylococcus species did not 
generate any inaccurate Staphylococcus species identifications. 
When comparing the results of laboratory versus clinical strains, it was 
hypothesized that laboratory strains would identify with greater accuracy using laser-light 
scattering than clinical isolates because laboratory strains were utilized to develop MIT 
Identifiers. Our results displayed 100% identification accuracy when identifying clinical 
isolates; while laboratory strains displayed identification accuracy greater than 95.0%. 
Clinical isolates were tested a minimum of 3 times with the MIT 1000; while laboratory 
strains were identified a minimum of 10 times. After performing these replication, we did 
not observe conflicting identifications in the samples tested. Overall, our concern that 
laser-light scattering identification could not be translated to clinical isolates was 
addressed. We can conclude that there is no significant difference in the identification 
accuracy between clinical isolates and laboratory strains. Additionally, none of the 
growth media tested displayed significant differences in bacterial identification accuracy.     
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CHAPTER THREE: IMMUNOMAGNETIC SEPARATION VIA ANTI-STAPH 
DYNABEADS 
 
 
 
 
INTRODUCTION 
 
Prior to the use of anti-Protein A DynaBeads, anti-Staph DynaBeads were utilized 
for S. aureus capture via IMS methods. Anti-Staph antibodies are antibodies raised 
against whole S. aureus cells as opposed to anti-Protein A antibodies which are raised 
against a surface protein specific to S. aureus. Specificity of anti-Staph DynaBeads for S. 
aureus was evaluated by determining the capture ability of the antibodies. We 
hypothesized that the anti-Staph antibodies conjugated to DynaBeads would specifically 
capture a significant concentration of S. aureus cells in both pure and mixed specimen 
samples.    
In order to determine specificity for S. aureus, anti-Staph DynaBeads were added 
to pure samples of S. aureus and M. luteus. The anti-Staph DynaBeads were then mixed 
for 1 hour for binding and washed to remove non-bound cells from the sample. The 
washed anti-Staph DynaBeads were then spot plated on agar plates and incubated at 37 ͦ C 
for 18 hours. To further assess anti-Staph DynaBead specificity for S. aureus, anti-Staph 
DynaBeads were added to separate samples containing S. aureus and other negative 
controls, B. subtilis, M. luteus, and S. marcescens, mixed for 1 hour for binding and 
washed to remove non-bound cells from the sample. The washed anti-Staph DynaBeads 
were then spread plated on agar plates to determine the capture efficiencies for the anti-
Staph DynaBeads when combined with positive and negative control strains. S. aureus 
mixed samples were also utilized to generate a more complex sample and replicate more 
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realistic sample collections. In order to determine the specificity of anti-Staph DynaBeads 
for S. aureus in mixed samples, S. aureus was mixed with each of the negative control 
strains: M. luteus, S. marcescens, and B. subtilis. Anti-Staph DynaBeads were added to 
each sample, mixed for 1 hour for binding and washed to remove non-bound cells from 
the sample. The anti-Staph DynaBeads were then quadrant streaked, incubated at 37 ͦ C 
for 18 hours and captured colonies were observed. The results of these experiments 
allowed us to determine the binding specificity and capture efficiency anti-Staph 
DynaBeads had for S. aureus and other negative control strains.   
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METHODS 
 
 
 
 
Preparation of anti-Staphylococcus DynaBeads 
 
Anti-Staph antibodies (Life Technologies) are antibodies raised against whole S. 
aureus cells as opposed to anti-Protein A antibodies which are raised against surface 
proteins specific to S. aureus. Anti-Staph DynaBeads were prepared as follows: 100 µL 
of magnetic beads (M-280 Streptavidin DynaBeads, Life Technologies) were transferred 
into a microcentrifuge tube and magnetically separated for 3 minutes in order to remove 
the storage buffer. The DynaBeads were resuspended in 450 µL of phosphate buffer 
saline (PBS, NaCl 137mM, KCl 2.7 mM, Na2HPO4 10mM, KH2PO4 1.8 mM) and mixed 
by a rotator (VWR, 10136-084) for 1 minute at room temperature. The DynaBeads were 
magnetically separated for 3 minutes, PBS was removed and the DynaBeads were 
resuspended in 450 µL of PBS. This process was repeated for a total of 3 washes. The 
prepared DynaBeads were stored in 100 µL of PBS and held at 4 ͦ C. 
Prepared DynaBeads were combined with 20 µL of biotin conjugated chicken 
anti-Staph antibodies (1 mg/ml, Life Technologies) and rotated for 1 hour. The 
DynaBeads and antibody mixture (now referred to as, anti-Staph DynaBeads) was then 
magnetically separated for 3 minutes. The PBS was removed and the anti-Staph 
DynaBeads were resuspended in 450 µL of PBS and rotated for 1 minute at room 
temperature. The anti-Staph DynaBeads were then magnetically separated for 3 minutes. 
This washing process was repeated for a total of 4 washes. The washed anti-Staph 
DynaBeads were stored in 100 µL of PBS and held at 4 ͦ C. 
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Development of IMS methods via anti-Staph DynaBeads and specificity testing 
 
To determine the capture efficiencies of the anti-Staph DynaBeads to S. aureus in 
pure culture, bacterial specimens were 10-fold serial diluted from an overnight culture 
(Undiluted overnight culture to 10-7) in 450 µL of filtered TSB, 20 µL of the anti-Staph 
DynaBeads were added to the specimens and rotated for 1 hour at 22 ͦ C. The samples 
were then magnetically separated for 1 minute, the TSB was removed and anti-Staph 
DynaBeads were resuspended in 450 µL of wash buffer, PBS plus 0.01% bovine serum 
albumin (BSA, VWR). The samples were then rotated for 1 minute at room temperature 
and then magnetically separated for 1 minute. This process was repeated for a total of 4 
washes. The anti-Staph DynaBeads were then transferred into a sterile microcentrifuge 
tubes with 100 µL of PBS. The transfer liquid (PBS) was then removed and the 
DynaBeads were resuspended in 100 µl of PSB. The dilutions were then spot plated (5 
µl) to determine the binding specificity of the anti-Staph DynaBeads for S. aureus. M. 
luteus was used as a negative control. To further determine the specificity of anti-Staph 
DynaBeads, serial dilutions were created for S. aureus, as previously described, and 
mixed with 20 µl of anti-Staph DynaBeads for one hour. The solution from the 10-4 
dilution was spread plated on LB media and incubated at 37◦C for 18 hours. M. luteus, S. 
marcescens, and B. subtilis were used as negative controls. Plates were observed after 18 
hours and growth was recorded.  
Anti-Staph DynaBead specificity for S. aureus capture when challenged with a 
mixture of other bacteria was also conducted. Serial dilutions were created as previously 
mentioned with equal amounts of S. aureus and M. luteus, S. aureus and S. marcescens, 
and S. aureus and B. subtilis. S. aureus in combination with B. subtilis was plated on LB 
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agar, S. aureus in combination with S. marcescens was plated on LB agar, and S. aureus 
in combination with M. luteus was plated on MSA agar to differentiate between S. aureus 
and M. luteus. This experiment allowed us to determine anti-Staph DynaBead specify for 
S. aureus alone, when challenged with other negative control bacteria.  
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RESULTS 
 
 
 
 
Anti-Staph DynaBead specificity testing 
  
To determine the capture efficiencies of the anti-Staph DynaBeads to S. aureus in 
pure culture, 20 µl of conjugated anti-Staph DynaBeads were mixed with 10-fold serial 
dilutions of overnight cultures (Undiluted to 10-7) of S. aureus for one hour. The dilutions 
were then spot plated to determine the binding specificity of the anti-Staph DynaBeads 
for S. aureus. M. luteus was used as a negative control. Figure 15 displays binding of S. 
aureus to anti-Staph DynaBeads and only minimal binding for M. luteus the negative 
control in the undiluted concentration. To further determine the specificity of anti-Staph 
DynaBeads, serial dilutions were created for S. aureus, as previously described, and 
mixed with conjugated anti-Staph  
Figure 15. Binding specificity for anti-Staph DynaBeads for S. aureus in pure culture 
spot plates.  5 µl of bound anti-Staph DynaBeads were spot plated on LB media for 
each dilution to display the bacteria that has bound to the anti-Staph DynaBeads. M. 
luteus was used as a negative control.  
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DynaBeads for one hour. The solution from the 10-4 dilution was spread plated on LB 
media and incubated at 37◦C for 18 hours. M. luteus, S. marcescens, and B. subtilis were 
used as negative controls. Figure 16 displays anti-Staph DynaBeads ability to bind S. 
aureus as well as other negative controls. A final experiment was used to determine anti-
Staph DynaBead specificity for S. aureus when challenged with other bacteria (Figure 
17). Serial dilutions were created as previously mentioned with equal amounts of S. 
aureus and M. luteus, S. aureus and S. marcescens, and S. aureus and B. subtilis. The 
Figure 16. Binding specificity for anti-Staph DynaBeads for S. aureus in 
pure culture. 100 µl of bound anti-Staph DynaBeads were spread plated 
on LB media to display anti-Staph DynaBead specificity for S. aureus. 
M. luteus, S. marcescens, and B. subtilis were used as negative controls. 
Nonspecific binding was observed. 
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results displayed specificity for S. aureus when challenged with M. luteus (Figure 17C); 
however when challenged with B. subtilis and S. marcescens the anti-Staph DynaBeads 
did not display full specificity for S. aureus alone.  
The preliminary experiments using anti-Staphylococcus antibodies and 
DynaBeads displayed the ability to capture both S. aureus and multiple negative controls 
but not S. aureus specifically. These findings suggest that a more specific antibody was 
necessary to isolate S. aureus alone. Therefore, we proposed to use antibodies against 
Protein A, a surface protein specific to S. aureus but not S. epidermidis or other negative 
controls, to isolate S. aureus from mixed samples 18.    
 
 
 
 
 
 
 
Figure 17. Binding specificity of anti-Staph DynaBeads for S. aureus when challenged 
with equal amounts of negative control bacteria. A. S. aureus in combination with B. 
subtilis plated on LB agar, showing presence of both bacteria, B.  S. aureus in 
combination with S. marcescens plated on LB agar, showing presence of both bacteria, 
and C. S. aureus in combination with M. luteus plated on Mannitol Salt agar to 
differentiate between S. aureus and M. luteus, showing specificity for S. aureus alone.  
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DISCUSSION 
 
 
 
 
Identification methods, such as single laser-light scattering have the ability to 
rapidly identify pathogens and lead to the quicker administration of treatments. However, 
rapid identification needs to be paired with a method of rapid capture or isolation of that 
bacteria prior to identification. In order to bypass the lengthy step of growing bacteria on 
agar plates, we proposed to utilize IMS as our mode of S. aureus isolation prior to rapid 
laser-light identification. Previous studies have utilized IMS in order to isolate L. 
monocytogenes from pure culture and from contaminated whole milk and ground beef 
samples.   
Utilizing anti-Staph antibodies which are antibodies raised against whole S. 
aureus cells, our data initially displayed binding of S. aureus to anti-Staph DynaBeads 
and only minimal binding for M. luteus the negative control in the undiluted 
concentration (Figure 15). The deduced that the presence of minimal growth of M. luteus 
on this spot plate could have been due to inefficient washing methods or due to direct 
binding of M. luteus to anti-Staph DynaBeads. 
To further determine the specificity of anti-Staph DynaBeads, 10-fold serial 
dilutions from overnight cultures were created for S. aureus, and mixed with anti-Staph 
DynaBeads for one hour. The solution from the 10-4 dilution was spread plated on LB 
media. M. luteus, S. marcescens, and B. subtilis were used as negative controls. Figure 16 
displayed anti-Staph DynaBeads ability to capture S. aureus with high efficiency. In 
addition to a high capture rate for S. aureus, S. marcescens and B. subtilis were captured 
at a high rate when combined with anti-Staph DynaBeads. We speculate that the high 
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capture rate of S. marcescens and B. subtilis could be attributed to non-specific binding of 
these microbes to the antibodies, DynaBeads, or surfaces of the microcentrifuge tubes. M. 
luteus, much like the results displayed in Figure 15, was captured at a low rate by anti-
Staph DynaBeads.   
A final experiment was used to determine anti-Staph DynaBead specificity for S. 
aureus when challenged with other bacteria (Figure 17). The results displayed specificity 
for S. aureus when challenged with M. luteus (Figure 17C); however when challenged 
with B. subtilis and S. marcescens the anti-Staph DynaBeads did not display full 
specificity for S. aureus alone (Figure 17A and 17B). These results suggest that the non-
specific binding was occurring during our IMS procedure. The non-specific binding 
could have been attributed to inadequate washing during the IMS procedure or due to the 
anti-Staph antibody. If non-specific binding was due to the antibody itself, we speculate 
that the antibody was developed to bind to a cell surface protein that may be commonly 
found on the surfaces of many microbes, resulting in the binding of not only S. aureus but 
other negative control strains. 
The experiments using anti-Staphylococcus antibodies and DynaBeads displayed 
the ability to capture both S. aureus and multiple negative controls but not S. aureus 
specifically. The anti-Staph DynaBeads are raised against whole S. aureus cells, rather 
than to a specific antigen found on the surface of S. aureus.  Due to this feature of anti-
Staphylococcus antibodies, the antibodies have the potential to recognize and bind to the 
surface of many bacteria species. These findings suggest that a more specific antibody is 
necessary to isolate S. aureus alone. Therefore, we propose to use antibodies against 
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Protein A, a surface protein specific to S. aureus but not S. epidermidis or other negative 
controls, to isolate S. aureus from samples containing a mixture of bacteria 18.    
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CHAPTER FOUR: IMMUNOMAGNETIC SEPARATION OF S. AUREUS VIA 
ANTI-PROTEIN A DYANBEADS 
 
 
 
 
INTRODUCTION 
 
Due to anti-Staph DynaBeads lack of specificity for S. aureus, we proposed to use 
antibodies against Protein A, which is specific for a surface protein unique to S. aureus in 
order to isolate S. aureus 18. Prior to specificity testing, we first needed to determine the 
optimal conditions for anti-Protein A DynaBead preparation and capture methods. Wash 
conditions were first evaluated to determine their effect on non-specific binding and the 
removal of unbound bacteria that could potentially be stuck to the walls or cap of 
microcentrifuge tubes. The following wash buffers were evaluated for washing 
efficiency: PBS, PBS + 0.1% BSA, and PBS + 0.01% Tween 20.  
After the establishment of optimal anti-Protein A DynaBead preparation and 
capture methods, we needed to determine anti-Protein A DynaBeads ability to capture S. 
aureus. To evaluate anti-Protein A DynaBead specificity for S. aureus, anti-Protein A 
DynaBeads were added to pure culture samples of S. aureus, mixed for 1 hour, washed 
with PBS + 0.01% Tween. The anti-Protein A DynaBeads were spread plated on agar 
plates and then incubated at 37 ͦ C for 18 hours. Capture efficiencies were then calculated 
and statistical significance was determined via one-way ANOVA Bonferroni multiple 
comparison test. This process was repeated with a diverse group of negative control 
strains. We hypothesized that anti-Protein A DynaBeads would have greater specificity 
for S. aureus than did anti-Staph DynaBeads. We further hypothesized that anti-Protein A 
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DynaBeads would specifically capture a significant concentration of S. aureus cells in 
both pure and mixed specimen samples. 
After determining anti-Protein A DynaBeads ability to capture S. aureus in pure 
cultures, we then sought to determine if our IMS methods could capture S. aureus from a 
more complex biological sample. To evaluate this, we performed our methods in whole 
milk which contains many competing proteins, enzymes, and other microbial species. We 
hypothesized that anti-Protein A DynaBeads would have specificity for S. aureus in 
whole milk; however, there would be a reduction in capture efficiency due to the increase 
in competing cells, fats, proteins, and particulates within the whole milk.  In order to 
determine this, anti-Protein A DynaBeads were added to whole milk containing S. aureus 
and capture efficiencies and statistical significance were calculated. This process was 
repeated with negative control strains that could be connected to milk contamination (B. 
subtilis and L. monocytogenes).  
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METHODS 
 
 
 
 
Preparation of anti-Protein A DynaBeads 
 
 Anti-Protein A DynaBeads were prepared as follows: 100 µL of magnetic beads 
(M-280 Streptavidin DynaBeads, Life Technologies) were transferred into a 
microcentrifuge tube and magnetically separated (Dynamag2, Life Technologies) for 3 
minutes in order to remove the storage buffer. The DynaBeads were resuspended in 450 
µL of PBS and mixed by a rotator for 1 minute at room temperature. The DynaBeads 
were magnetically separated for 3 minutes, PBS was removed and the DynaBeads were 
resuspended in 450 µL of PBS. This process was repeated for a total of 3 washes. The 
prepared DynaBeads were stored in 100 µL of PBS and held at 4 ͦ C. 
 Prepared DynaBeads were combined with 20 µL of biotin conjugated chicken 
anti-Protein A antibodies (1 mg/ml, ICL lab) and rotated for 1 hour. The DynaBead and 
antibody mixture (now referred to as, anti-Protein A DynaBeads) were then magnetically 
separated for 3 minutes. The PBS was removed and the anti-Protein A DynaBeads were 
resuspended in 450 µL of PBS and rotated for 1 minute at room temperature. The anti-
Table 4. Summary table of optimal conditions for enrichment step. This table 
includes the variations in variables for each experiment performed above. 
Optimal conditions are highlighted in yellow 
Conditio
n 
Growth 
Media 
Binding 
Temperatur
e 
Moveme
nt 
Bead 
Removal 
Growth Media 
Removal 
1 TSB 22 ͦ C No No No 
2 TSB 37 ͦ C No No No 
3 TSB 37 ͦ C 215 rpm No No 
4 TSB 37 ͦ C 250 rpm No No 
5 TSB 37 ͦ C 250 rpm Yes No 
6 Terrific Broth 37 ͦ C 250 rpm Yes No 
7 TSB 37 ͦ C 250 rpm Yes Yes 
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Protein A DynaBeads were then magnetically separated for 3 minutes. This washing 
process was repeated for a total of 4 washes. The washed anti-Protein A DynaBeads were 
stored in 100 µL of PBS and held at 4 ͦ C. Optimal conditions are shown highlighted in 
yellow in Table 4.  
ImmunoMagnetic Separation of S. aureus via anti-Protein A DynaBeads 
 
Development of IMS methods via anti-Protein A DynaBeads 
 
Bacterial strains were grown in TSB at 37 ͦ C for 18-24 hours. Ten-fold serial 
dilutions from overnight cultures of S. aureus were made in TSB media for experiments 
evaluating ImmunoMagnetic Separation and laser-light scatting identification.  
Fifty microliters of overnight bacterial cultures were 10-fold serial diluted in 450 
µL of filtered TSB (10-2-10-6), 20 µL of the anti-Protein A DynaBeads were added to the 
specimens and rotated for 1 hour at either 22 ͦ C or 37 ͦ C. The samples were then 
magnetically separated for 1-3 minutes, the TSB was removed and anti-Protein A 
DynaBeads were resuspended in 450 µL of wash buffer, PBS alone, PBS plus 0.1% 
bovine serum albumin (BSA, VWR), or PBS plus 0.01% Tween 20 (VWR). The samples 
were then rotated for 1 minute at room temperature and then magnetically separated for 
1-3 minutes. This process was repeated for a total of 4 washes. The anti-Protein A 
DynaBeads were then transferred into a sterile microcentrifuge tubes with 100 µL of 
PBS. The transfer liquid (PBS) was then removed and the DynaBeads were resuspended 
in 100 µl of PBS. The experimental conditions (magnetic separation time, wash buffer, 
tube type, and binding temperatures) were adjusted to determine the most efficient means 
for ImmunoMagnetic separation of targeted bacterial specimens.  
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To determine the efficiency of the anti-Protein A DynaBead protocol, the washing 
buffers were first evaluated. To determine if the wash buffer altered non-specific binding 
of bacteria to the walls or cap of microcentrifuge tubes, the use of PBS and PBS + 0.1% 
BSA were evaluated for washing efficiency. In order to evaluate the efficiency of each 
buffer, 10-fold serial dilutions (10-3 to 10-7) of overnight S. aureus cultures were created 
in TSB. To each dilution, 20 µl of anti-Protein A DynaBeads were added, rotated for 1 
hour, magnetically separated for 3 minutes and washed with 450 µl of either PBS or PBS 
+ 0.1% BSA. After adding 450 µl of appropriate wash buffer, the tubes were rotated for 1 
minute at 22 ͦ C, magnetically separated for 3 minutes and washed with 450 µl of the 
appropriate wash buffer. This process was repeated for a total number of 4 washed.  The 
washed anti-Protein A DynaBeads were then resuspended in 100 µl of PBS and 5 µl of 
the solution was spot plated on TBS agar plates and incubated at 37 ͦ C for 18 hours. 
Another 10-fold serial dilution set (10-3 to 10-7) was generated and 20 µl of DynaBeads 
alone were added and the same protocol was repeated. This dilution set was created to 
evaluate wash efficiency by media type.  
PBS and PBS + 0.01% Tween 20 were then evaluated for their ability to reduce 
non-specific binding.  To evaluate, S. aureus was 10-fold serial diluted (10-3 to 10-6) from 
overnight cultures in 450 µl of TSB. To each dilution, 20 µl of anti-Protein A DynaBeads 
were added and the same IMS protocol as above was repeated. The wash buffer under 
evaluation were either PBS or PBS + 0.01% Tween 20.  Another serial dilution set (10-3 
to 10-6) was generated and 20 µl of DynaBeads alone were added. After the washes, 100 
µl of each dilution was spread plated on TSB agar plates and incubated at 37 ͦ C for 18 
hours and colonies were counted in order to calculate and compare capture efficiencies. 
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Established IMS protocol for S. aureus capture  
  
Bacterial specimens were 10-fold serial diluted of overnight cultures (10-2 to 10-6) 
in 450 µL of TSB, 20 µL of the anti-Protein A DynaBeads were added to the specimens 
and rotated for 1 hour at 37 ͦ C. The samples were then magnetically separated for 3 
minutes, the TSB was removed and anti-Protein A DynaBeads were resuspended in 450 
µL of PBS plus 0.01% Tween 20. The samples were then rotated for 1 minute at room 
temperature and then magnetically separated for 3 minutes. This process was repeated for 
a total of 4 washes. The anti-Protein A DynaBeads were then transferred into sterile 
microcentrifuge tubes with 50 µL of PBS. The transfer liquid (PBS) was then removed 
and the DynaBeads were resuspended in 100 µl of PBS. 
Specificity testing in pure culture 
 
To determine anti-Protein A DynaBeads ability to capture S. aureus, 50 µl of S. 
aureus were mixed in 450 µl of buffer and 10-fold serial diluted from overnight cultures 
(10-1 to 10-8). Two sets of the same serial dilutions were prepared, 20 µl of anti-Protein A 
DynaBeads were added to one set of dilutions and mixed for 1 hour. The tube set 
containing the anti-Protein A DynaBeads were then magnetically separated and washed 
with 450 µl of PBS plus 0.01% Tween 20 to remove any unbound cells. After 4 washes 
the bound anti-Protein A DynaBeads were resuspended in 100 µl of PBS. Then 100 µl of 
DynaBeads were then spread plated on TSB plates and incubated at 37oC for 18 hours. 
Anti-Protein A DynaBeads were not added to the other set of dilutions. These dilutions 
were utilized to determine the initial input of bacteria in each sample (input). To 
determine the input for each dilution, each tube was vortexed for 10 seconds and 100 µl 
was spread plated on TSB agar plates and incubated at 37oC for 18 hours. After 
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incubation, colonies on each plate were counted and capture efficiencies were calculated. 
Capture efficiencies (CE) are defined as the percentage fraction of total bacteria captured 
on the surface of the anti-Protein A DynaBeads 90. Capture efficiencies are calculated 
using the number of unbound cells in the starting dilution (input). The equation for 
Capture efficiency is calculated using the following equation: Capture efficiency (%) = 
(1-B/A) x 100% 90.  A is the total number of cells present in the sample (CFU/ml) and B 
is the number of cells unbound to the anti-Protein A DynaBeads (CFU/ml, input).   
In a similar control experiment, S. epidermidis, S. intermedius, S. simulans, S. 
pyogenes, M. luteus, L. monocytogenes, E. faecalis, E. coli, and B. subtilis were used as 
negative controls to determine the anti-Protein A DynaBeads specificity for each.  
Capture efficiencies were determined using the same protocol mentioned above. These 
methods allowed us to determine the IMS binding limit (the fewest number of bacteria 
able to bind in a sample).  
Specificity testing in mixed culture 
 
To determine the specificity anti-Protein A DynaBeads have for S. aureus when 
challenged by other bacteria, S. aureus was mixed with an equal concentration of S. 
epidermidis which is a normal flora bacteria found on the skin and should not bind to 
anti-Protein A DynaBeads 15. To evaluate the specificity, serial dilutions were spread 
plated using previously established methods and incubated for at 37o C for 18 hours.    
Capture efficiencies were calculated and analyzed. These experiments were performed to 
establish the capture limit and specificity for our IMS protocol. (Results not shown) 
S. aureus IMS isolation from whole milk by anti-Protein A DynaBeads 
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To determine anti-Protein A DynaBeads ability to capture S. aureus from whole 
milk, S. aureus was 10-fold serial diluted from overnight cultures (10-2 to 10-6) in 450 µl 
of pasteurized whole milk. Two sets of the same serial dilutions (10-2 to 10-6) were 
prepared, 20 µl of anti-Protein A DynaBeads were added to one set of dilutions and 
mixed for 1 hour. The tube set containing the anti-Protein A DynaBeads were then 
magnetically separated for 3 minutes and washed with 450 µl of PBS plus 0.01% Tween 
20 to remove any unbound cells. After 4 washes the bound anti-Protein A DynaBeads 
were resuspended in 100 µl of PBS. The 100 µl of DynaBeads are then spread plated on 
TSB plates and incubated at 37oC for 18 hours. Anti-Protein A DynaBeads were not 
added to the other set of dilutions. These dilutions were utilized to determine the initial 
input of bacteria in each sample (input). To determine the input for each dilution, each 
tube was vortexed for 10 seconds and 100 µl was spread plated on TSB agar plates and 
incubated at 37oC for 18 hours. After incubation, colonies on each plate were counted and 
capture efficiencies were calculated. 
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RESULTS 
 
 
 
 
Analysis of anti-Protein A DynaBead S. aureus capture specificity  
 
Development of anti-Protein A DynaBead protocol for S. aureus IMS capture 
 
To determine the efficiency of the anti-Protein A DynaBead protocol, the washing 
buffers were first evaluated. To determine if the wash buffer altered non-specific binding 
of bacteria to the walls or cap of microcentrifuge tubes, or the DynaBeads themselves, the 
use of PBS and PBS + 0.1% BSA were evaluated for washing efficiency. In order to 
evaluate the efficiency of each media, 10-fold serial dilutions of overnight cultures (10-3 
to 10-7) were generated with S. aureus. To each dilution, 20 µl of anti-Protein A 
DynaBeads were added, rotated for 1 hour, and washed four times with 450 µl of either 
PBS or PBS + 0.1% BSA.  Another serial dilution set (10-3 to 10-7) was generated and 20 
Figure 18. Binding capacity of anti-Protein A DynaBeads for S. aureus, PBS versus PBS + 
0.1% BSA. After the addition of anti-Protein A DynaBeads and IMS protocol, samples were 
resuspended in 100 µl of PBS and 5 µl of the solution was spot plated on TSB agar.  
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µl of DynaBeads alone were 
added. This dilution set was 
created to evaluate wash 
efficiency by media type. Figure 
18 displays similar results in 
both capture and washing 
efficiency between PBS and PBS 
+ 0.01% BSA. To prevent further 
non-specific binding via wash 
buffer, PBS and PBS + 0.01% 
Tween 20 were then evaluated 
for their ability to reduce non-
specific binding.  To evaluate, S. 
aureus was 10-fold serial diluted 
from overnight cultures (10-3 to 
10-6). To each dilution, 20 µl of anti-Protein A DynaBeads were added, rotated for 1 hour 
at 22 ͦ C, and washed four times with 450 µl of either PBS or PBS + 0.01% Tween 20.  
Another serial dilution set (10-3 to 10-6) was generated and 20 µl of DynaBeads alone 
were added. After the washes with the appropriate media, 100 µl of each dilution was 
spread plated and colonies were counted in order to calculate and compare capture 
efficiencies. Figure 19 displays the colonies input into a sample compared to the non-
specific binding for the same dilution. When washed with PBS alone, the DynaBeads 
alone (non-specific binding) displayed an average capture efficiency of 0.83% + 0.41. 
Figure 19. Non-specific binding evaluated with different 
wash buffer. PBS and PBS + 0.01% Tween 20 were 
evaluated for their ability to reduce non-specific binding 
during IMS protocol. (A) S. aureus input in 10-5 dilution 
after 4 washes with PBS alone. (B) 10-5 S. aureus 
dilution after 4 washes with PBS alone. (C) S. aureus 
input in 10-5 dilution after 4 washes with PBS + 0.01% 
Tween 20. (D) 10-5 S. aureus dilution after 4 washes 
with PBS + 0.01% Tween 20.  
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When washed with PBS + 0.01% 
Tween 20, the DynaBeads alone 
displayed an average capture 
efficiency of 0.17% + 0.13.  
Although, the media type did not did 
not display a significant difference in 
the option between PBS and PBS + 
0.01% Tween 20, PBS + Tween did 
perform better when reducing non-
specific binding. This led us to use 
PBS + Tween as our main wash 
buffer after the addition of anti-
Protein A DynaBeads to a sample. After using the established protocol, a gram stain of S. 
aureus bound to anti-Protein A DynaBeads was conducted and imaged (Figure 20).  
Analysis of capture efficiency and specificity of anti-Protein A DynaBeads for S. 
aureus in pure culture 
 
In order to determine anti-Protein A DynaBeads specificity for S. aureus, pure 
cultures of S. aureus and 8 negative controls were utilized to determine capture 
efficiencies for each strain when using anti-Protein A DynaBeads. To perform this 
analysis, overnight cultures of the bacteria strains were 10-fold serial diluted (10-3 to 10-6) 
in duplicate. One set of dilutions were utilized as the initial input of bacteria to the 
sample and the second set was utilized in order to calculate the number of cells captured 
by anti-Protein A DynaBeads (Figure 22 and 23). Capture efficiency was calculated as 
follows: Capture efficiency (%) = (1-B/A) x 100% 90.  A is the total number of cells 
Figure 20. Gram stain of anti-Protein A 
DynaBeads bound to S. aureus. Gram stain 
was observed under 1000x magnification. S. 
aureus are the purple cells (average diameter 
is 0.6 µm) and the anti-Protein A DynaBeads 
are shown as yellow spheres (diameter 2.8 
µm).      
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present in the sample (CFU/ml) and B is the number of cells unbound to the anti-Protein 
A DynaBeads (CFU/ml, input) (Table 5).   
Capture efficiencies (%) were determined from pure culture samples. The average 
capture efficiencies were as follows: S. aureus 78.21 + 2.01, B. subtilis 0.00 + 0.00, E. 
faecalis 0.55 + 0.21, E. coli 0.00 + 0.00, M. luteus 0.00 + 0.01, S. epidermidis 0.26 + 
0.34, S. intermedius 0.84 + 0.95, S. simulans 0.07 + 0.09, S. pyogenes 0.37 + 0.69. 
Statistical analysis using one-way ANOVA with a Bonferroni multiple comparison test 
displayed all negative controls to have P-values less than 0.001 when compared to S. 
aureus 6538 (Figure 24).  
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Figure 21. Anti-Protein A IMS capture for strains containing Protein A-like proteins. After 1 
hour of anti-Protein A DynaBead exposure and a final wash (to remove unbound 
bacteria), the anti-Protein A DynaBeads were resuspended in 100 µl of PBS and spread 
plated on LB agar (10-6 dilution is pictured).  (A) S. aureus input (the initial amount of 
bacteria added to the sample without anti-Protein A DynaBead exposure) (B) S. aureus 
bacteria captured (C) S. aureus combined with DynaBeads alone (D) S. intermedius input 
(the initial amount of bacteria added to the sample without anti-Protein A DynaBead 
exposure) (E) S. intermedius bacteria captured (F) S. intermedius combined with 
DynaBeads alone. 
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Figure 22. Specificity of conjugated anti-Protein A DynaBeads for negative controls 
alone. After 1 hour of anti-Protein A DynaBead exposure and a final wash (to remove 
unbound bacteria), the anti-Protein A DynaBeads were resuspended in 100 µl of PBS and 
spread plated on LB agar (10-6 dilution is pictured).  (A) S. epidermidis input (the initial 
amount of bacteria added to the sample without anti-Protein A DynaBead exposure) (B) 
S. epidermidis bacteria captured (C) S. epidermidis combined with DynaBeads alone (D) 
S. pyogenes input (E) S. pyogenes bacteria capture (F) S. pyogenes combined with 
DynaBeads alone (G) M. luteus input (H) M. luteus bacteria capture (I) M. luteus 
combined with DynaBeads alone. 
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Figure 23. Specificity of conjugated anti-Protein A DynaBeads for negative controls alone. 
After 1 hour of anti-Protein A DynaBead exposure and a final wash (to remove unbound 
bacteria), the anti-Protein A DynaBeads were resuspended in 100 µl of PBS and spread 
plated on LB agar (10-6 dilution is pictured).  (A) E. faecalis input (the initial amount of 
bacteria added to the sample without anti-Protein A DynaBead exposure) (B) E. faecalis 
bacteria captured (C) E. faecalis combined with DynaBeads alone (D) E. coli input (E) E. coli 
bacteria capture (F) E. coli combined with DynaBeads alone. (G) B. subtilis input (H) B. 
subtilis bacteria capture. (I) B. subtilis combined with DynaBeads alone. 
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Table 5. Capture Efficiencies for anti-Protein A DynaBeads from pure culture.  
Organism Dilution Capture Efficiency (%) 
S. aureus 
10-3 82.08 + 14.36 
10-4 82.08 + 14.36 
10-5 78.59 + 15.75 
10-6 70.10 + 23.99 
S. epidermidis 
10-3 0.84 + 0.20 
10-4 0.84 + 0.20 
10-5 0.84 + 0.20 
10-6 0.25+ 0.50 
S. pyogenes 
10-3 0.37 + 0.31 
10-4 1.33 + 1.18 
10-5 0.00 + 0.00 
10-6 0.00 + 0.00  
E. faecalis 
10-3 0.55 + 0.03 
10-4 0.66 + 0.36 
10-5 0.25 + 0.18 
10-6 1.27 + 1.87 
E. coli 
10-3 0.00 + 0.00 
10-4 0.00 + 0.00 
10-5 0.00 + 0.00 
10-6 0.00 + 0.00 
M. luteus 
10-3 0.01 + 0.01 
10-4 0.00 + 0.00 
10-5 0.00 + 0.00 
10-6 0.00 + 0.00 
B. subtilis 
10-3 0.00 + 0.00 
10-4 0.00 + 0.00 
10-5 0.00 + 0.00 
10-6 0.00 + 0.00 
S. intermedius 
10-3 1.87 + 0.00 
10-4 0.67 + 0.00 
10-5 0.00 + 0.00 
S. simulans 
10-3 0.05 + 0.03 
10-4 0.05 + 0.01 
10-5 0.17 + 0.12 
10-6 0.00 + 0.00 
S. chromogenes 
10-3 2.03 + 0.00 
10-5 0.00 + 0.00 
10-6 0.00 + 0.00 
S. haemolyticus 
10-3 1.48 + 0.00 
10-5 0.00 + 0.00 
10-6 0.00 + 0.00 
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Analysis of S. aureus isolation from whole milk 
 
To determine anti-Protein A DynaBeads ability to capture S. aureus from whole 
milk, capture efficiencies were calculated for S. aureus, B. subtilis, L. monocytogenes, 
and DynaBeads alone. Initial inputs of the bacteria were also determined in order to 
calculate capture efficiencies. The whole milk alone was also plated out in order to 
determine the concentration of naturally occurring bacteria within the milk (Figure 25). 
Whole milk alone typically contains multiple Bacillus species, Lactobacillus species, and 
Streptococcus species. S. aureus is rarely found in Pasteurized milk from healthy 
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Anti-Protein A Specificity for S. aureus in Pure Culture
Figure 24. Anti-Protein A specificity for S. aureus in pure culture. Sa refers to S. aureus 6538, 
Bs refers to B. subtilis, Ef refers to E. faecalis, Ec refers to E. coli, Ml refers to M. luteus, Se 
refers to S. epidermidis, Si refers to S. intermedius, Ss refers to S. simulans, Sp refers to S. 
pyogenes, Sc refers to S. chromogenes, and Sh refers to S. haemolyticus. For each bacteria 
strain, average bacteria inputs were calculated (CFU/ml): S. aureus 3.81 x 109 CFU/ml, B. 
subtilis 6.04 x 109 CFU/ml, E. faecalis 1.18 x 109 CFU/ml, E. coli 1.04 x 109 CFU/ml,, M. luteus 
1.06 x 109 CFU/ml, S. epidermidis 2.21 x 109 CFU/ml, S. intermedius 7.47 x 108 CFU/ml, S. 
simulans 1.15 x 109 CFU/ml, S. pyogenes 3.07 x 107 CFU/ml.  S. chromogenes 4.86 x108 
CFU/ml and S. haemolyticus 4.20 x 108 CFU/ml. Statistical significance (P-value) was 
determined by comparing results of each negative control strain to S. aureus.  One asterisk (*) 
denotes a P-value less than 0.001. 
* * * * * * * * * * 
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animals; however, animals with mammary glands infected by S. aureus can lead to milk 
contamination 26. To determine if S. aureus could be captured with anti-Protein A 
DynaBeads from a complex biological fluid like whole milk, 50 µl of an overnight 
culture of S. aureus was initially mixed with 450 µl of whole milk (10-1 dilution). This 
sample was then used to make further 10-fold dilutions down to 10-6. Twenty microliters 
of anti-Protein A DynaBeads were added to the 10-3, 10-5, and 10-6 dilutions, then 
processed as described above to assess capture efficiencies.   
Capture efficiencies within whole milk displayed reduced efficiency for S. aureus 
compared to capture in TSB media (Table 5). In whole milk, S. aureus capture efficiency 
was 54.89% + 5.78, while negative controls B. subtilis and L. monocytogenes capture 
efficiencies were both 0.00% + 0.00. DynaBeads alone (not bound to anti-Protein A 
antibodies) were also added to samples containing S. aureus, B. subtilis, and L. 
monocytogenes where they displayed 0.00% + 0.00 capture efficiencies in all samples 
(Table 5, Figure 26 and 27). Statistical analysis using one-way ANOVA Bonferroni 
multiple comparison test displayed significance with a P-value less than 0.001 when 
comparing the capture efficiencies of B. subtilis to S. aureus, L. monocytogenes to S. 
aureus, and DynaBeads alone to S. aureus.  
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Figure 25. Naturally occurring bacteria from whole milk. Naturally occurring bacteria 
contaminants found within pasteurized whole milk. Performed in duplicate, 10-fold dilutions 
of pure whole milk were generated and 100 µl of a 10-6 dilution was spread plated on TSB agar 
and incubated at 37 ͦ C for 18 hours. (A) Naturally occurring bacteria from pasteurized whole 
milk performed (B) performed in duplicate from separate milk sources. Bacterial strain 
variation displayed between the two milk sources. 
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Figure 26. Specificity of anti-Protein A antibodies for S. aureus alone in pure culture of 
whole milk. 100 µl of 10-6 dilution was spread plated of bound anti-Protein A DynaBeads. 
(A) S. aureus input without anti-Protein A DynaBeads. (B) S. aureus captured from milk by 
anti-Protein A DynaBeads. (C) S. aureus combined with DynaBeads alone in milk (D) L. 
monocytogenes input without anti-Protein A DynaBeads. (E) L. monocytogenes captured 
from milk by anti-Protein A DynaBeads. (F) L. monocytogenes combined with DynaBeads 
alone (G) B. subtilis input without anti-Protein A DynaBeads. (H) B. subtilis captured from 
milk by anti-Protein A DynaBeads (I) B. subtilis combined with DynaBeads alone. 
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Table 6. Average capture efficiencies of S. aureus from pasteurized whole milk.  
Organism Dilution Average Capture Efficiency (%) 
S. aureus 
10-3 57.53 + 3.87 
10-5 57.53 + 3.87 
10-6 49.62 + 7.32 
B. subtilis 
10-3 0.00 + 0.00 
10-5 0.00 + 0.00 
10-6 0.00 + 0.00 
L. monocytogenes 
10-3 0.00 + 0.00 
10-5 0.00 + 0.00 
10-6 0.00 + 0.00 
DynaBeads alone 
10-3 0.00 + 0.00 
10-5 0.00 + 0.00 
10-6 0.00 + 0.00 
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Figure 27. Average capture efficiencies (%) of S. aureus 6538 and negative control strains in 
whole milk and for each bacteria strain, average bacteria inputs were calculated (CFU/ml).  S. 
aureus capture efficiency of 54.89% + 5.78 with an initial input of 5.54 x 109 CFU/ml, B. 
subtilis capture efficiency of 0.00% + 0.00 with an initial input of 7.22 x 108 CFU/ml, and L. 
monocytogenes with a capture efficiency of 0.00% + 0.00 with an initial input of 2.44 x 109 
CFU/ml.  Statistical significance (P-value) was determined by comparing results of each 
negative control strain to S. aureus.  One asterisk (*) denotes a P-value less than 0.001. 
 
* * * 
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DISCUSSION 
 
 
 
 
 Due to anti-Staph DynaBeads lack of capture specificity for S. aureus, anti-
Protein A antibodies were chosen in order to aid in increasing capture efficiency rate for 
S. aureus and reduce the rate of non-specific binding of negative controls. Protein A is 
expressed on the surface of nearly all S. aureus strains and occupies approximately 7% of 
the S. aureus cell surface 30.  By utilizing an antibody that is specific to a S. aureus 
surface protein rather than against whole S. aureus cells (anti-Staph DynaBeads), we 
hoped to increase the specificity of capture and reduce non-specific binding. Prior to the 
use of anti-Protein A DynaBeads, we needed to develop IMS methods for the greatest 
recovery of S. aureus cells. To develop anti-Protein A IMS methods, we needed to 
determine if the wash buffer altered non-specific binding of bacteria to the walls or cap of 
microcentrifuge tubes, or the DynaBeads themselves. The following media types were 
utilized in the washing process and evaluated for efficiency: PBS, PBS + 0.1% BSA, and 
PBS + 0.01% Tween 20. PBS is a balanced salt solution used for a variety of cell culture 
applications including washing cells 70. BSA is commonly used to reduce non-specific 
hydrophobic binding and Tween 20 has been used as a blocking agent in immunoassays 
73,85. The addition of a 0.1% of either BSA or 0.01% Tween 20 to PBS was evaluated for 
its effect on non-specific binding.  
The first comparison of media wash efficiency was done by evaluating PBS and 
PBS + 0.1% BSA. Anti-Protein A DynaBeads were added to pure cultures of S. aureus, 
mixed for one hour to induce capture and then washed 4 times with either PBS or PBS + 
0.1% BSA. After the washing process, the samples were spot plated on TSB agar and 
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incubated at 37 ͦ C for 18 hours. Figure 18 shows that there is not a significant difference 
between the capture rate when using either PBS or PBS + 0.1% BSA. To determine if 
non-specific binding was the cause of S. aureus capture, rather than actual anti-Protein A 
capture, DynaBeads alone were added to pure cultures of S. aureus, mixed for one hour 
to induce capture and then washed 4 times with either PBS or PBS + 0.1% BSA.   After 
the washing process, the samples were spot plated on TSB agar and incubated at 37 ͦ C for 
18 hours.  Figure 18 showed no non-specific binding when using PBS as a wash buffer, 
while PBS + BSA displayed minimal non-specific capture.  
 To further analyze wash buffer efficiency, non-specific binding between PBS was 
then compared to PBS + 0.01% Tween 20. To evaluate PBS and PBS + Tweens ability to 
reduce non-specific binding, DynaBeads alone were added to samples containing S. 
aureus and mixed for one hour to induce capture and then washed 4 times with either 
PBS or PBS + 0.01% Tween. When washed with PBS alone, the DynaBeads alone (non-
specific binding) displayed an average capture efficiency of 0.83% + 0.41. When washed 
with PBS + 0.01% Tween, the DynaBeads alone (non-specific binding) displayed an 
average capture efficiency of 0.17% + 0.13. Although there was not a significant 
difference in non-specific binding, we decided to utilize PBS + 0.01% Tween in order to 
reduce as much non-specific binding within a sample as possible.   
Upon the development of IMS methods for S. aureus capture, the specificity of 
anti-Protein A DynaBeads for S. aureus in pure culture was next evaluated. Both capture 
efficiencies of S. aureus and non-specific binding of negative controls were calculated 
and statistical significance was determined by one-way ANOVA Bonferroni multiple 
comparison test.  By performing this set of experiments we wanted to determine if anti-
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Protein A DynaBeads had specificity for S. aureus compared to negative controls. We 
utilized a wide variety of negative controls to represent organisms that may be found in 
naturally occurring swab specimens including: M. luteus, S. pyogenes, and S. epidermidis 
which represent normal skin microbes. E. faecalis, which can sometimes be found in skin 
ulceration with S. aureus. E. coli, a Gram-negative gut microbe containing pili on its cell 
surface, was also utilized as a negative control to challenge our IMS methods 41.  
Utilizing IMS with anti-Protein A DynaBeads resulted an average S. aureus capture 
efficiency of 82.00% of the initial input of cells. Comparing the capture efficiency of S. 
aureus to other normal flora negative controls (M. luteus, S. pyogenes, E. faecalis and S. 
epidermidis) and E. coli, the negative control strains were captured on average less than 
1.00% and statistical significance was displayed with P-value less than 0.001 (Table 5, 
Figure 24).  
S. simulans and S. intermedius were also utilized to test the specificity of the anti-
Protein A DynaBeads specificity for capturing S. aureus. As previously mentioned, 
Protein A is a surface protein specific to S. aureus. However, after conducting a BLAST 
search of S. aureus Protein A (Table 1), it was determined that a limited number of other 
Staphylococcus species also contain a protein with some homology to S. aureus Protein 
A. To determine if our antibody was specific to S. aureus Protein A, S. intermedius (61% 
Percent Identity to S. aureus Protein A) and S. simulans (34% Percent Identity to S. 
aureus Protein A) were utilized as negative controls.  Comparing the average capture 
efficiency of S. aureus (82.00%) to the capture efficiencies of Protein A containing 
Staphylococcus strains, S. intermedius and S. simulans both had average capture 
efficiencies less than 1.00% (Table 5, Figure 24). These results display statistically 
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significant evidence to suggest that anti-Protein A DynaBeads have specificity for S. 
aureus.  
To test anti-Protein A DynaBead specificity for S. aureus in a complex biological, 
IMS methods were performed in pasteurized whole milk and capture efficiencies for S. 
aureus and other negative controls were determined. Milk related pathogens include: 
Salmonella, E. coli, Listeria, and Staphylococcus 16. Non-pathogenic strains such as 
Streptococcus, Bacillus, and Lactobacillus can also be found in milk samples even after 
Pasteurization 72. Figure 25 displays the naturally occurring bacteria that were found 
specifically in our Pasteurized whole milk which included Lactobacillus, Streptococcus, 
and Bacillus species. For our negative control strains we chose L. monocytogenes and B. 
subtilis. L. monocytogenes is commonly responsible for dairy related food-poisoning and 
B. subtilis has also been found to be an environmental contaminant in milk 25,72. As 
described above, IMS methods were performed in whole milk and capture efficiencies 
and statistical significance was calculated for S. aureus and negative controls.  After IMS 
methods were performed, S. aureus capture efficiency was 54.89% + 5.78, B. subtilis 
capture efficiency was 0.00% + 0.00, and L. monocytogenes capture efficiency was 
0.00% + 0.00 (Table 6, Figure 27).  When comparing the capture efficiencies of S. aureus 
to both negative controls, we observed statistical significance with a P-value less than 
0.001 (Figure 27). DynaBeads alone were also added to samples containing each of the 
above mentioned bacteria. There was no non-specific binding, further supporting the 
efficiency of our IMS washing method with PBS containing 0.01% Tween (Table 6, 
Figure 26).     
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In conclusion, anti-Protein A DynaBeads displayed significant specificity for S. 
aureus in both pure culture and when isolated from whole milk. In pure culture, IMS 
capture efficiency was 82% compared to 54% in whole milk. Although S. aureus was 
captured in whole milk, we hypothesized that there would be a reduction in recovery rate 
due to the complexity of the fluid and the increased rate of competing cells and particles. 
If IMS methods were to be performed in whole milk in the future, increasing the 
capture/binding time of anti-Protein A DynaBeads from 1 hour to 2 hours could 
potentially lead to an increase in capture efficiency for S. aureus.   
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CHAPTER FIVE: COMBINING IMMUNOMAGNETIC SEPARATION AND 
SINGLE LASER-LIGHT SCATTERING FOR RAPID IDENTIFICATION 
 
 
 
 
INTRODUCTION 
 
In the previous chapter, protocol for IMS of S. aureus utilizing anti-Protein A 
DynaBeads was established. Following S. aureus capture, an enrichment step needed to 
be developed in order to obtain a concentration of bacteria high enough for laser-light 
scattering identification (which is approximately 1,000 bacteria cells per milliliter) 37. To 
determine the optimal conditions for enrichment, variables were altered in order to 
determine optimal conditions for the IMS of S. aureus and identification via laser-light 
scattering. Variables that were altered included: media volume, media filtration versus 
non-filtered media, enrichment duration, and sample aeration (200-300 rpm), and 
incubation. 
A protocol was established for anti-Protein A DynaBead S. aureus capture, 
enrichment of bacteria, and subsequent identification via laser-light scattering. Following 
the development of this protocol, the ability to capture, enrich, and identify S. aureus via 
laser-light scattering was tested on S. aureus and the negative control strains (S. 
pyogenes, M. luteus, E. faecalis, L. monocytogenes, E. aerogenes, and E. coli). In order to 
evaluate its specificity for S. aureus, S. aureus was measured alone or mixed with 
negative controls to create a more complex and realistic specimen sample. The capture 
efficiency and accuracy of the rapid identification methods were then assessed.  Percent 
identified as Staphylococcus species was calculated and statistical significance was 
determined by a one-way ANOVA Bonferroni multiple comparison test.  
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In typical wound infection and skin/soft tissue infections, specimens are collected 
from these types of infection sites on sterile swabs. In order to determine if IMS could 
successfully capture S. aureus from a swab sample, we inoculated sterile swabs with a 
broth culture containing dilutions of S. aureus. The swabs were transferred to a test tube 
containing TSB growth media. The previously established capture, enrichment, and 
identification protocol was used to isolate the bacteria from swab specimens. Since S. 
aureus is not always isolated in pure culture from the site of infection, we created mixed 
swab samples to replicate a sample containing normal skin microorganisms. S. aureus 
were combined with S. pyogenes, M. luteus, and S. epidermidis and the previously 
mentioned methods were repeated. To further assess our developed methods, bacteria 
taken from healthy human skin and nose swabs were mixed with S. aureus. The use of 
bacteria from human swab samples (likely containing multiple bacterial species) allowed 
us to increase the complexity of the samples and replicate a mixture of microbes that 
might be seen from an actual infection site. This set of experiments allowed us to assess 
if our IMS and laser-light scattering identification methods can be utilized on complex 
biological samples. Finally, in order to determine the amount of bacteria that grows 
within a sample during the enrichment stage over time, samples were magnetically 
separated after each hour for five hours. The average growth (CFU/ml) by enrichment 
over a 5 hour time frame from swab specimen collection was determined in order to 
quantify the number of progeny produced during the enrichment step. To calculate this, 
after IMS capture, each hour, the tubes were magnetically separated for 3 minutes and the 
supernatant was spread plated on TSB agar and incubated at 37 ͦ C for 18 hours. Colony 
forming units were then calculated.   
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METHODS 
 
 
 
 
IMS capture, enrichment, and laser-light scattering identification  
 
Development of IMS capture, enrichment, and laser-light scattering identification 
methods 
 
Once anti-Protein A DynaBeads specificity was been established for S. aureus, an 
enrichment step needed to take place in order to obtain the proper concentration of 
bacteria for laser-light scattering identification (approximately 1,000 bacteria cells per 
milliliter) 37. To determine the optimal conditions for enrichment 10-fold serial dilutions 
from overnight cultures (10-3 to 10-8) were utilized to represent different concentrations of 
the bacteria that could be obtained in a clinical sample. Variables that were altered in 
order to determine optimal conditions for IMS and laser-light scattering identification 
protocol occurred during each step of the protocol. During IMS protocol the temperature 
(22 ͦ C and 37 ͦ C) during IMS binding was tested for effects on binding efficiency. 
Enrichment step variables altered included: growth media volume, filtered versus non-
filtered media, enrichment duration, and sample aeration (200-300 rpm). MIT sample 
preparation variables altered included: (1) directly testing bacteria resuspended in filtered 
TSB growth media or (2) testing bacteria resuspended in filtered water after pelleting the 
capture cells and removing TSB growth media. We also tested if DynaBead removal, 
after the enrichment step and prior to laser-light scattering identification, would increase 
the accuracy of identification since DynaBeads are small particles that could interfere 
with laser-light scattering measurements.   
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In order to determine optimal conditions, the previously establish IMS protocol 
was used with the exception of a temperature change during binding from 22 ͦ C to 37 ͦ C. 
After washing the 20 µl of conjugated anti-Protein A DynaBeads bound to S. aureus in 
the sample, the DynaBeads were resuspended in 25-50 µl of either non-filtered TSB or 
filtered TSB liquid media (Thermo Scientific Nalgene vacuum filtration system, 0.2 
micron filter) and transferred into sterile microcentrifuge tubes. The tube transfer limited 
the unwanted transfer of unbound cells that could be stuck on the sides/tops of the tubes. 
After the transfer, the tubes were incubated at 37◦C for 1-5 hours.  Each hour the tubes 
were magnetically separated for a minimum of 3 minutes. MIT sample preparation was 
either conducted by either directly testing about 1.0 µl of the supernatant from the media 
or by pelleting the cells within the sample (centrifuging for 1 minute at top speed), 
removing the liquid media and resuspending the cells in filtered water before testing in 
the MIT 1000. The optimal time for enrichment and the optimal bacterial concentrations 
were evaluated for accurate identification of S. aureus using laser-light scattering 
analysis. The final variable evaluated during MIT sample preparation was the addition of 
one 150 µl filtered water wash after pelleting and removing the media. All of the above 
mentioned variables were adjusted one at a time in order to establish IMS capture, 
enrichment, and laser-light scattering identification methods for rapid S. aureus detection.  
IMS capture, enrichment, and laser-light scattering identification (established 
methods) 
 
Fifty microliters of bacterial specimens from overnight cultures were 10-fold 
serial diluted (10-2 to10-6) in 450 µL of TSB, 20 µL of the anti-Protein A DynaBeads 
were added to the specimens and rotated for 1 hour at 37 ͦ C. The samples were then 
magnetically separated for 3 minutes, the TSB was removed and anti-Protein A 
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DynaBeads were resuspended in 450 µL of PBS plus 0.01% Tween 20. The samples 
were then rotated for 1 minute at room temperature and then magnetically separated for 3 
minutes. This process was repeated for a total of 4 washes. The anti-Protein A 
DynaBeads were then transferred into a sterile microcentrifuge tubes with 50 µL of PBS. 
The transfer liquid (PBS) was then removed and the DynaBeads were resuspended in 50 
µl of filtered TSB. 
The bacteria captured by the anti-Protein A DynaBeads were enriched in 50 µL of 
filtered TSB. The surface tension of each sample was broken and the tubes were shaken 
at 250 rpm and incubated at 37 ͦ C for 5 hours. The samples were vortexed for 20-30 
seconds and magnetically separated for 3 minutes. The supernatant was removed and 
transferred to a new microcentrifuge tube. This step was performed in order to reduce 
DynaBead transfer, which may interfere with laser-light scattering measurements. The 
supernatant was pelleted (centrifuged for 1 minute at 14000 rpm) and the media was 
removed. The pellet was then washed with 150 µL of filtered water, vortexed to break up 
the pellet and centrifuged for 1 minute at top speed. The filter water was then removed 
and the pelleted bacteria is then ready for laser-light scattering analysis.  Filtered water 
(10-50 µL) was then added to the prepared sample, vortexed for 20-30 seconds and 
magnetically separated for 3 minutes. A portion of the sample was loaded into a prepared 
water vial and a laser-light scattering identification analysis is conducted.   
Rapid laser-light scattering identification from IMS samples (experiment) 
 
 In order to determine the efficiency of the established IMS laser-light scatting 
rapid identification methods, the procedure was tested on both S. aureus and the negative 
control strains (S. pyogenes, M. luteus, E. faecalis, L. monocytogenes, E. aerogenes, and 
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E. coli) in order to evaluate its specificity for S. aureus alone. Using previously 
established methods, bacterial strains alone were 10-fold serial diluted from overnight 
cultures in duplicate and anti-Protein A DynaBeads were added to each dilution (10-2 - 
10-6) of one set of the serial dilutions. The other set of serial dilutions were utilized for 
counting the initial input of bacteria into each sample. To determine the initial input for 
each sample, each tube was vortexed for 10 seconds to resuspend the bacteria in the tube 
and 100 µl was spread plated on TSB agar plates and incubated at 37 ͦ C for 18 hours 
(performed in triplicate). Colony forming units per milliliter (CFU/ml) were calculated 
for each tube. The samples containing DynaBeads went through the established IMS and 
enrichment protocol and were then tested in the MIT 1000 for laser-light scattering 
identification. The same methods were then utilized in order to perform combination 
challenges between S. aureus and equal concentrations of the negative controls (S. aureus 
and S. pyogenes, S. aureus and M. luteus, S. aureus and E. faecalis, S. aureus and L. 
monocytogenes, S. aureus and E. aerogenes, S. aureus and E. coli). Combination 
challenges utilizing S. aureus and two negative controls were also utilized (S. aureus, S. 
pyogenes, and M. luteus AND S. aureus, S. pyogenes, and E. coli).   
IMS capture, enrichment, and laser-light scattering identification from swab 
specimens 
 
Swab specimen collection technique 
 
 Swab specimen collection protocol was attained and altered from Panpradist et al. 
2014. Ten-fold serial dilutions (10-2 to 10-6) of S. aureus overnight cultures were 
generated from overnight cultures in TSB growth media. Swabs (Sterile polyester tipped 
applicator swabs, VWR) were submerged in initial serial dilutions for 10 seconds. Swabs 
were then submerged in a transfer microcentrifuge tube containing 450 µl of filtered 
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TSB. To translate the obtained bacteria to the new microcentrifuge tubes, the submerged 
swabs were dragged along the edge of the tube in a circular path at a rate of 1 cycle per 
second (1 HZ) for 10 seconds (10 second 1 HZ side twirl). The swab agitation was done 
by hand utilizing the timer as a reference for manual control of transfer time 68.   
Development of IMS capture, enrichment, and laser-light scattering identification for 
swab specimens   
 
The most common types of S. aureus infections in humans are skin infections, 
wound infections, and abscesses 55 14. Specimens are typically collected from these types 
of infection sites on sterile swabs. In order to demonstrate that our developed IMS 
capture methods could successfully capture S. aureus from swab samples, we inoculated 
sterile swabs with a broth culture containing dilutions (10-2 to 10-6) of S. aureus. The 
swabs were transferred to a test tube containing growth media and vortexed to dislodge 
the bacterial cells from the swab to create a suspension. To capture the bacteria in the 
sample, swabs were removed and 10-20 µl of anti-Protein A DynaBeads were added to 
the tubes.  Previously established IMS protocol was used to isolate the bacteria from 
swab specimens.  The MIT instrument then measured the laser-light scattering pattern of 
the bacteria in the sample and determine the bacteria matches the known Identifier for 
Staphylococcus species (or S. aureus or MRSA when those Identifiers become available).  
Since S. aureus is not always isolated in pure culture from the site of infection, we then 
created mixed swab samples to replicate normal skin microorganisms. S. aureus was then 
combined with S. pyogenes, M. luteus, and S. epidermidis and the previously mentioned 
methods were be repeated.   
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Rapid bacterial identification from IMS swab samples (established protocol) 
 
Bacterial strains were grown in TSB at 37 ͦ C for 18-24 hours. Serial dilutions of 
cultures in filtered TSB (0.2 micron filter) were produced for IMS and MIT laser-light 
scattering identification testing. Serial dilutions were made in low-binding polymer 
microcentrifuge tubes (Life Technologies).  
Bacterial specimens were obtained from 10-fold serial dilutions of overnight 
cultures via swab collection. Swab collections (10 seconds) were transferred into a 
microcentrifuge tube with 450 µL of filtered TSB. 20 µL of the anti-Protein A 
DynaBeads were added to the swab collected specimens and rotated for 1 hour at 37 ͦ C. 
The samples were then magnetically separated for 3 minutes, the filtered TSB was 
removed and the anti-Protein A DynaBeads were resuspended in 450 µL of PBS plus 
0.01% Tween 20. The samples were then rotated for 1 minute at room temperature and 
then magnetically separated for 3 minutes. This process was repeated for a total of 4 
washes. The anti-Protein A DynaBeads were then transferred into natural microcentrifuge 
tubes with 50 µL of filtered TSB. 
Anti-Protein A DynaBeads were enriched in 50 µL of filtered TSB. The surface 
tension of each sample was broken and the tubes were shaken at 250 rpm and incubated 
at 37 ͦ C for 5 hours.  The samples were vortexed for 20-30 seconds and magnetically 
separated for 3 minutes. The supernatant was removed and transferred to a new 
microcentrifuge tube. The supernatant was pelleted (centrifuged for 1 minute at top speed 
14000 rpm) and the media was removed. The pellet was then washed with 150 µL of 
filtered water, vortexed to break up the pellet and centrifuged for 1 minute at top speed. 
The filter water was then removed and the pelleted bacteria was resuspended in 10-50 µl 
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of filter water, vortexed for 20-30 seconds and magnetically separated for 3 minutes. A 
portion of the sample (about 1 µl) was loaded into a prepared water vial and a MIT laser-
light scattering identification test was conducted using previously mentioned MIT sample 
protocol.   
Rapid bacterial identification from IMS swab samples (experiment) 
 
 In order to determine the accuracy of the established IMS and laser-light 
scattering identification swab methods, the procedure was tested on both S. aureus and 
the negative control strains (S. pyogenes, M. luteus, E. faecalis, L. monocytogenes, E. 
aerogenes, and E. coli) in order to evaluate its specificity for S. aureus alone. Using 
previously established IMS swab methods, bacterial strains alone were 10-fold serial 
diluted from overnight cultures in duplicate and the specimens were obtained by swabs, 
and dislodged into microcentrifuge tubes containing 450 µl of growth media, and 20 µl of 
anti-Protein A DynaBeads were added to each 10-fold dilution (10-2 - 10-6) of one set of 
the serial dilutions. The other set of serial dilutions were utilized for counting the initial 
input of bacteria into each sample. To determine the initial input for each sample, each 
tube was vortexed for 10 seconds to resuspend the bacteria in the tube and 100 µl was 
spread plated on TSB agar plates and incubated at 37 ͦ C for 18 hours (performed in 
triplicate). Colony forming units per milliliter (CFU/ml) were calculated for each tube. 
The samples containing DynaBeads went through the established IMS swab protocol and 
were tested in the MIT 1000 for laser-light scattering identification.  
 The same methods were then utilized to capture and identify S. aureus in a mixed 
swab sample containing equal amounts of S. aureus and one negative control. The 
pairings were S. aureus and S. pyogenes, S. aureus and M. luteus, S. aureus and E. 
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faecalis, S. aureus and L. monocytogenes, S. aureus and E. aerogenes, S. aureus and E. 
coli. Combination challenges containing S. aureus and two negative controls were also 
utilized (S. aureus, S. pyogenes, and M. luteus AND S. aureus, S. pyogenes, and E. coli).   
Rapid S. aureus identification following IMS of samples containing mixed human nose 
and skin microflora 
 
 Nose swabs were collected by first soaking the sterile swab in 0.9% saline 
solution. The swab was then inserted approximately 2 cm (~3/4 inches) into one nostril. 
The swab was then rotated against the anterior nasal mucosa for 10 seconds. The 
obtained specimen was then transferred into a microcentrifuge tube containing 450 µl of 
TSB media. Skin swabs were collected by first soaking the sterile swab in a 0.9% saline 
solutions. The swab was the rubbed against the inner forearm skin in a 2” x 2” square for 
10 seconds.  The obtained specimen was then transferred into a microcentrifuge tube 
containing 450 µl of TSB media. To the obtained swab samples, 50 µl of a S. aureus 
overnight culture was added and the existing swab IMS protocol, enrichment, and MIT 
laser-light scattering identification was conducted. This procedure was tested on the 
following samples: (1) skin swab and S. aureus, (2) nose swab and S. aureus, (3) skin, 
nose and S. aureus, (4) nose swab alone, (5) skin swab alone, and (6) an overnight of a 
direct nose swab.  
Calculation of average bacteria growth by enrichment over time 
 
The average growth (CFU/ml) by enrichment over a 5 hour time frame from swab 
specimen collection was determined in order to quantify the number of progeny produced 
during the enrichment step. To calculate this, 10-fold serial dilutions of a S. aureus 
overnight culture were created and 20 µl anti-Protein A DynaBeads were added to each 
dilution (10-3 to 10-6).  Using previously established IMS methods, S. aureus cells 
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captured by anti-Protein A DynaBeads were resuspended in filtered TSB agar and 
incubated at 37 ͦ C for 5 hours while shaken at 250 rpm. Each hour, the tubes were 
vortexed for 10 seconds, magnetically separated for 3 minutes, and the supernatant (50 
µl) was spread plated on TSB agar and incubated at 37 ͦ C for 18 hours. Colony forming 
units were then calculated. 
Calculation of capture efficiencies and statistical analysis 
 
Capture efficiencies (CE) are defined as the percentage fraction of total bacteria 
captured on the surface of the anti-Protein A DynaBeads 90. Capture efficiencies are 
calculated using the number of unbound cells in the starting dilution (input). The equation 
for Capture efficiency is calculated using the following equation: Capture efficiency(%) 
= (1-B/A) x 100% 90.  A is the total number of cells present in the sample (CFU/ml) and 
B is the number of cells unbound to the anti-Protein A DynaBeads (CFU/ml, input). 
Statistical analysis of capture efficiencies and MIT laser-light scattering identifications 
were performed with Prism 3 program (GraphPad Software, Inc.). Statistical significance 
was measured by one-way ANOVA utilizing Bonferroni multiple comparison test. 
Statistical significance was defined with a P-value less than 0.05 when comparing 
negative control strains to positive control S. aureus 6538. A P-value greater than 0.05 
indicated that there was no statistical significance between capture efficiencies and laser-
light scattering results when comparing negative controls to S. aureus 6538.  
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RESULTS 
 
 
 
 
Development of IMS capture, enrichment, and rapid identification by laser-light 
scattering 
 
In order to determine the optimal conditions for post-IMS rapid identification of 
S. aureus by laser-light scattering, various conditions were evaluated for their effects on 
successful identification.  The following variables were altered: media type for 
enrichment, filtration of media for enrichment, removal of DynaBeads during 
enrichment, time of enrichment, removal of growth media after enrichment, and 
resuspension of captured bacteria in filtered water. Percent identification as 
Staphylococcus species under set conditions were evaluated and a one-way ANOVA 
Bonferroni multiple comparison test was conducted in order to determine statistical 
significance. 
Figure 28 displays the results of S. aureus laser-light identification analysis under 
varying conditions. The no bead removal section of Figure 28 protocol was performed as 
indicated in the methods section with the following modifications: samples were bound in 
filtered TSB media at 22 ͦ C, 1-3 hours of enrichment in filtered TSB at 37 ͦ C, and 
magnetic separation of anti-Protein A DynaBeads and direct addition of supernatant to 
MIT vials for laser-light scattering analysis. These variables resulted in S. aureus 
identifying as Staphylococcus species in 30% of samples. The shaken at 215 rpm section 
of Figure 28 protocol was as follows: IMS methods performed in filtered TSB media at 
22 ͦ C, 1-3 hours of enrichment in filtered TSB while shaken at 215 rpm at 37 ͦ C, 
magnetic separation of anti-Protein A DynaBeads and direct addition of supernatant to 
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MIT vials for laser-light scattering analysis. These conditions resulted in S. aureus 
identifying as Staphylococcus species in 45% of samples. The incubated binding section 
of Figure 28 protocol was as follows: IMS methods performed in filtered TSB media at 
37 ͦ C, 1-3 hours of enrichment in filtered TSB while shaken at 215 rpm at 37 ͦ C, 
magnetic separation of anti-Protein A DynaBeads and direct addition of supernatant to 
MIT vials for laser-light scattering analysis. Under these conditions, S. aureus identified 
as Staphylococcus species in 36% of samples. The shaken at 250 rpm section of Figure 
28 protocol was as follows: IMS methods performed in filtered TSB media at 37 ͦ C, 1-3 
hours of enrichment in filtered TSB while shaken at 250 rpm at 37 ͦ C, magnetic 
separation of anti-Protein A DynaBeads and direct addition of supernatant to MIT vials 
for laser-light scattering analysis. These conditions resulted in S. aureus identifying as 
Staphylococcus species in 44% of samples. The bead removal section of Figure 28 
protocol was as follows: IMS methods performed in filtered TSB media at 37 ͦ C, 1-2 
hours of enrichment in filtered TSB while shaken at 250 rpm at 37 ͦ C, after 1-2 hours of 
enrichment, anti-Protein A DynaBeads were removed and the enrichment incubation of 
samples resumed, magnetic separation of anti-Protein A DynaBeads and direct addition 
of supernatant to MIT vials for laser-light scattering analysis. S. aureus identified as 
Staphylococcus species in 64% of samples. The Terrific broth section of Figure 28 
protocol was as follows: IMS methods performed in filtered Terrific broth media at 37 ͦ C, 
1-3 hours of enrichment in filtered TSB while shaken at 250 rpm at 37 ͦ C, after 1-2 hours 
of enrichment, anti-Protein A DynaBeads were removed and the enrichment incubation 
of samples resumed, magnetic separation of anti-Protein A DynaBeads and direct 
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addition of supernatant to MIT vials for laser-light scattering analysis.  Under these 
conditions, S. aureus identified as Staphylococcus species in 50% of samples.  
The optimal conditions protocol was established as follows:  IMS methods were 
performed in filtered TSB media at 37 ͦ C, 1-5 hours of enrichment in filtered TSB while 
shaken at 250 rpm at 37 ͦ C, after enrichment anti-Protein A DynaBeads were removed 
and so was the TSB media (by pelleting the cells in the supernatant), S. aureus cells were 
then resuspended in filtered water, vortexed (to break up the pellet) and samples were 
then added to MIT vials for laser-light scattering analysis.  When these conditions were 
utilized, S. aureus identified as Staphylococcus species in 80% of samples (Figure 28). 
After statistical analysis using a one-way ANOVA Bonferroni multiple comparison test, 
P-values were greater than 0.05 for all conditions when compared to the established 
optimal conditions. This displayed no statistical significant difference between any of the 
conditions; however, when optimal conditions were utilized to identify S. aureus as 
Staphylococcus species via laser-light scattering, 80% of the samples identified 
accurately.  
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Analysis of rapid laser-light scattering detection from pure IMS samples 
 
Upon the establishment of IMS, enrichment, and laser-light scattering 
identification methods, identification of S. aureus was then evaluated in both pure S. 
aureus culture samples and mixed bacteria cultures (Figures 29 and 30).  Percent 
identified as Staphylococcus species from pure cultures displayed with an average initial 
input of 4.86 x 109 CFU/ml, S. aureus identified as Staphylococcus species via laser-light 
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Analysis of IMS and MIT Optimal Conditions
Figure 28. Analysis of IMS and MIT optimal conditions. IMS and MIT conditions were 
altered in order to determine the optimal conditions for the highest percent identified as 
Staphylococcus species for S. aureus. No bead removal resulted in S. aureus identifying as 
Staphylococcus species in 30% of samples. When samples were shaken at 215 rpm this 
resulted in S. aureus identifying as Staphylococcus species in 45% of samples. When the 
samples were incubated during anti-Protein A DynaBead binding at 37 ͦ C, S. aureus 
identified as Staphylococcus species in 36% of samples. When samples were shaken at 250 
rpm this resulted in S. aureus identifying as Staphylococcus species in 44% of samples. When 
anti-Protein A DynaBeads were removed after 1-2 hours of enrichment, S. aureus identified 
as Staphylococcus species in 64% of samples. When IMS and MIT methods were performed 
in filtered Terrific Broth, rather than filtered TSB, S. aureus identified as Staphylococcus 
species in 50% of samples. Optimal conditions included the removal of anti-Protein A 
DynaBeads and removal of enrichment media after 5 hours of enrichment; when these 
conditions were utilized, S. aureus identified as Staphylococcus species in 80% of samples. 
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scattering 80% of the time. With an average initial input of 3.97 x 109 CFU/ml, M. luteus 
falsely identified as Staphylococcus species via laser-light scattering 12.5% of the time. 
E. aerogenes with an average initial input of 2.15 x 108 CFU/ml, E. coli with an average 
initial input of 4.46 x 108 CFU/ml, E. faecalis with an average initial input of 1.75 x 109 
CFU/ml, L. monocytogenes with an average initial input of 2.60 x 109 CFU/ml, and S. 
pyogenes with an average initial input of 5.60 x 108 CFU/ml all identified as 
Staphylococcus species via laser-light scattering 0.00% of the time. Statistical analysis 
via one-way ANOVA Bonferroni multiple comparison test displayed P-values of less 
than 0.001 for all negative control strains when comparing the results of percent 
identified as Staphylococcus species of each negative control strain to percent identified 
as Staphylococcus species for S. aureus.   
In order to determine percent identified as Staphylococcus species from mixed 
samples, multi-microbial samples were generated in order to replicate more realistic 
clinical samples that are often polymicrobial. When in pure culture, S. aureus identified 
as Staphylococcus species via laser-light scattering 80% of the time with an initial input 
of 4.86 x 109 CFU/ml. S. aureus + E. aerogenes with an initial input, 2.15 x 108 CFU/ml 
identified as Staphylococcus species via laser-light scattering 50% of the time. S. aureus 
+ E. coli with an initial input of 4.46 x 108 CFU/ml identified 0% of the time. S. aureus + 
E. faecalis with an initial input of 1.75 x 109 CFU/ml identified 50% of the time.  S. 
aureus + L. monocytogenes with an initial input, 2.60 x 109 CFU/ml identified 60% of the 
time.  S. aureus + M. luteus with an initial input of 3.98 x 109 CFU/ml identified 75% of 
the time.  S. aureus + S. pyogenes with an initial input of 5.60 x 108 CFU/ml identified 
75% of the time. S. aureus + S. pyogenes + M. luteus identified 75% of the time. S. 
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aureus + S. pyogenes + E. coli identified 0% of the time. Statistical analysis via one-way 
ANOVA Bonferroni multiple comparison test displayed P-values of less than 0.05 when 
comparing the results of percent identified as Staphylococcus species of S. aureus with 
multi-microbial samples containing E. coli. Specifically, when S. aureus was mixed with 
E. coli and when S. aureus was mixed with E. coli and S. pyogenes P-values were less 
than 0.05. 
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Figure 29. Percent identified as Staphylococcus species from pure samples. S. aureus 
identified as Staphylococcus species via laser-light scattering 80% of the time with an initial 
input of 4.86 x 109 CFU/ml. M. luteus identified as Staphylococcus species via laser-light 
scattering 12.5% of the time with an initial input of 3.97 x 109 CFU/ml. E. aerogenes (initial 
input, 2.15 x 108 CFU/ml), E. coli (initial input, 4.46 x 108 CFU/ml), E. faecalis (initial input, 
1.75 x 109 CFU/ml), L. monocytogenes (initial input, 2.60 x 109 CFU/ml), and S. pyogenes 
(initial input, 5.60 x 108 CFU/ml) all identified as Staphylococcus species via laser-light 
scattering 0.00% of the time. Statistical significance (P-value) was determined by comparing 
results of each negative control strain to S. aureus.  One asterisk (*) denotes a P-value less 
than 0.001. 
* 
* * * * * 
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Figure 30. Percent identified as Staphylococcus species from mixed samples. S. aureus 
identified as Staphylococcus species via laser-light scattering 80% of the time with an initial 
input of 4.86 x 109 CFU/ml. S. aureus + E. aerogenes (initial input, 2.15 x 108 CFU/ml) 
identified as Staphylococcus species via laser-light scattering 50% of the time. S. aureus + E. 
coli (initial input, 4.46 x 108 CFU/ml) identified 0% of the time. S. aureus + E. faecalis 
(initial input, 1.75 x 109 CFU/ml) identified 50% of the time.  S. aureus + L. monocytogenes 
(initial input, 2.60 x 109 CFU/ml) identified 60% of the time.  S. aureus + M. luteus (initial 
input 3.98 x 109 CFU/ml) identified 75% of the time.  S. aureus + S. pyogenes (initial input, 
5.60 x 108 CFU/ml) identified 75% of the time. S. aureus + S. pyogenes + M. luteus identified 
75% of the time. S. aureus + S. pyogenes + E. coli identified 0% of the time. Statistical 
significance (P-value) was determined by comparing results of each negative control strain to 
S. aureus.  One asterisk (*) denotes a P-value less than 0.05. 
* * 
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Figure 31. Percent identified as Staphylococcus species from mixed specimens by dilution. 
After IMS capture and bacterial enrichment, samples underwent laser-light scattering 
identification. Percent identified as Staphylococcus species was determined for each set of 
samples. Bar colors represent different concentrations of initial input of S. aureus to samples. 
Estimated equal concentrations of S. aureus and negative control strains were added to each 
sample. Statistical analysis was conducted by one-way ANOVA Bonferroni multiple 
comparison test, *denotes P < 0.01 and **denotes P < 0.001. Each dilution by bacteria was 
compared to each other for statistical analysis, interspecies comparison was not conducted.  
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Analysis of rapid laser-light scattering detection from IMS swab samples 
 
In clinical settings, specimen collection on swabs is one of the most utilized form 
of specimen collection for infections of skin and soft tissues. In order to determine if S. 
aureus could be identified from swab specimen collection, pre-established IMS and laser-
light scattering identification methods were utilized and evaluated for accuracy of 
identification. Upon the establishment of IMS, enrichment, and laser-light scattering 
identification methods from swab samples, identification of S. aureus was then evaluated 
in both swab pure samples and swab mixed samples (Figures 32 and 33).  Percent 
identified as Staphylococcus species from pure swab samples displayed that S. aureus 
identified as Staphylococcus species via laser-light scattering 82% of the time with an 
average initial input of 1.12 x 108 CFU/ml. S. pyogenes misidentified as Staphylococcus 
species via laser-light scattering 10% of the time with an initial input of 2.22 x 107 
CFU/ml. E. aerogenes with an average initial input of 2.77 x 108 CFU/ml, E. coli with an 
average initial input of 6.19 x 106 CFU/ml, E. faecalis with an average initial input of 
3.49 x 108 CFU/ml, L. monocytogenes with an average initial input of 1.75 x 108 CFU/ml, 
M. luteus with an average initial input of 7.35 x 107 CFU/ml, human nose swab with an 
average initial input of 3.00 x 108 CFU/ml, direct human nose swab with an average 
initial input of 1.82 x 105 CFU/ml, human skin swab with an average initial input of 4.05 
x 108 CFU/ml all identified as Staphylococcus species via laser-light scattering 0.00% of 
the time. Statistical significance (P-value) was determined by comparing results of each 
negative control strain to S. aureus via one-way ANOVA Bonferroni multiple 
comparison test.  Statistical significance, P-value less than 0.001 was present for all 
negative controls when compared to S. aureus (Figure 32). Figure 31 displays how the 
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percent identified as Staphylococcus species differed by each dilution for the averages 
displayed in Figure 30.  
By generating mixed, multi-microbial samples, we were able to evaluate the 
accuracy of our methods for S. aureus capture and identification when challenged with 
multiple species of bacteria in a sample. Evaluation of S. aureus capture and 
identification from multi-microbial samples gave a more realistic analysis of S. aureus 
capture from clinical swab samples.  In order to evaluate mixed swab specimens, percent 
identified as Staphylococcus species from mixed swab samples was recorded and 
statistical significance was determined by one-way ANOVA Bonferroni multiple 
comparison test. S. aureus identified as Staphylococcus species via laser-light scattering 
83% of the time with an initial input of 4.86 x 109 CFU/ml. S. aureus + E. aerogenes 
with an initial input of 2.77 x 108 CFU/ml identified as Staphylococcus species via laser- 
light scattering 78% of the time. S. aureus + E. coli with an initial input of 6.19 x 106 
CFU/ml identified 29% of the time. S. aureus + E. faecalis with an initial input of 3.49 x 
108 CFU/ml identified 29% of the time.  S. aureus + L. monocytogenes with an initial 
input of 1.75 x 108 CFU/ml identified 57% of the time.  S. aureus + M. luteus with an 
initial input of 7.35 x 107 CFU/ml identified 71% of the time.  S. aureus + S. pyogenes 
with an initial input of 2.22 x 107 CFU/ml identified 71% of the time. S. aureus + a 
human nose swab with an initial input of 3.00 x 108 CFU/ml identified 75% of the time. 
S. aureus + a human skin swab with an initial input of 4.05 x 108 CFU/ml identified 75% 
of the time. S. aureus + a human nose swab + and a human skin swab identified 70% of 
the time. S. aureus + S. pyogenes + M. luteus identified 43% of the time. S. aureus + S. 
pyogenes + E. coli identified 0% of the time. Statistical significance (P-value) was 
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determined by comparing results of each negative control strain to S. aureus.  Statistical 
significance was found with a P-value less than 0.01 when S. aureus + S. pyogenes + E. 
coli was compared to S. aureus alone (Figure 33). Figure 34 displays how the percent 
identified as Staphylococcus species differed by each dilution for the averages displayed 
in Figure 33.  
The average growth (CFU/ml) by enrichment over a 5 hour time frame from swab 
specimen collection was determined in order to quantify the number of progeny produced 
during the enrichment step. To calculate this, after IMS capture, the S. aureus cells 
captured by anti-Protein A DynaBeads were resuspended in filtered TSB agar and 
incubated at 37 ͦ C for 5 hours while shaken at 250 rpm. Each hour, the tubes were 
magnetically separated for 3 minutes and the supernatant was spread plated on TSB agar 
and incubated at 37 ͦ C for 18 hours. Colony forming units were then calculated. At hour 0 
of enrichment, average growth was 4.73 x 107 CFU/ml, after 1 hour of enrichment 
average growth was 2.19 x 108 CFU/ml, after 2 hours of enrichment average growth was 
4.57 x 108 CFU/ml, after 3 hours of enrichment average growth was 2.66 x 109 CFU/ml, 
after 4 hours of enrichment average growth was 4.36 x 109 CFU/ml, and after 5 hours of 
enrichment average growth was 1.27 x 1010 CFU/ml (Figure 36). 
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Figure 32. Percent identified as Staphylococcus species from pure swab samples. S. aureus 
identified as Staphylococcus species via laser-light scattering 82% of the time with an initial 
input of 1.12 x 108 CFU/ml. S. pyogenes identified as Staphylococcus species via laser-light 
scattering 10% of the time with an initial input of 2.22 x 107 CFU/ml. E. aerogenes (initial 
input, 2.77 x 108 CFU/ml), E. coli (initial input, 6.19 x 106 CFU/ml), E. faecalis (initial input, 
3.49 x 108 CFU/ml), L. monocytogenes (initial input, 1.75 x 108 CFU/ml), M. luteus (initial 
input, 7.35 x 107 CFU/ml), human nose swab (initial input, 3.00 x 108 CFU/ml), direct human 
nose swab (initial input, 1.82 x 105 CFU/ml), human skin swab (initial input, 4.05 x 108 
CFU/ml) all identified as Staphylococcus species via laser-light scattering 0.00% of the time. 
Statistical significance (P-value) was determined by comparing results of each negative 
control strain to S. aureus.  One asterisk (*) denotes a P-value less than 0.001. 
* 
* * * * * * * * 
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Figure 33. Percent identified as Staphylococcus species from mixed swab samples. S. aureus 
identified as Staphylococcus species via laser-light scattering 83% of the time with an initial 
input of 4.86 x 109 CFU/ml. S. aureus + E. aerogenes (initial input, 2.77 x 108 CFU/ml) 
identified as Staphylococcus species via laser-light scattering 78% of the time. S. aureus + E. 
coli (initial input, 6.19 x 106 CFU/ml) identified 29% of the time. S. aureus + E. faecalis 
(initial input, 3.49 x 108 CFU/ml) identified 29% of the time.  S. aureus + L. monocytogenes 
(initial input, 1.75 x 108 CFU/ml) identified 57% of the time.  S. aureus + M. luteus (initial 
input 7.35 x 107 CFU/ml) identified 71% of the time.  S. aureus + S. pyogenes (initial input, 
2.22 x 107 CFU/ml) identified 71% of the time. S. aureus + Nose (initial input, 3.00 x 108 
CFU/ml) identified 75% of the time. S. aureus + Skin swab (initial input, 4.05 x 108 CFU/ml) 
identified 75% of the time. S. aureus + Nose + Skin identified 70% of the time. S. aureus + S. 
pyogenes + M. luteus identified 43% of the time. S. aureus + S. pyogenes + E. coli identified 
0% of the time. Statistical significance (P-value) was determined by comparing results of each 
negative control strain to S. aureus.  One asterisk (*) denotes a P-value less than 0.01. 
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Figure 34. Percent identified as Staphylococcus species from mixed swab specimens by 
dilution. Percent identified as Staphylococcus species was determined for each set of swab 
samples. Bar colors represent different concentrations of initial input of S. aureus to samples. 
Estimated equal concentrations of S. aureus and negative control strains were added to each 
sample. Statistical analysis was conducted by one-way ANOVA Bonferroni multiple 
comparison test, **denotes P < 0.01 and *denotes P < 0.001. Each dilution by bacteria was 
compared to each other for statistical analysis, interspecies comparison was not conducted. 
* ** 
** 
** 
** ** ** ** 
*** * ** 
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Figure 35. Percent identified as Staphylococcus species from whole milk samples. After IMS 
capture and bacterial enrichment, samples underwent laser-light scattering identification. 
Percent identified as Staphylococcus species was determined for each set of samples. Samples 
were 10-fold serial diluted from an overnight of S. aureus or B. subtilis, Sa-1 represents the 10-
2 S. aureus serial dilution (initial input 2282000 CFUs), Sa-2 represents the 10-3 S. aureus serial 
dilution (initial input 228200 CFUs), Sa-3 represents the 10-4 S. aureus serial dilution (initial 
input 22820 CFUs),  Sa-4 represents the 10-5 S. aureus serial dilution (initial input 2282 CFUs), 
Sa-5 represents the 10-6 S. aureus serial dilution (initial input 275 CFUs), Sa-6 represents the 
10-7 S. aureus serial dilution (initial input 27 CFUs), and Bs represents the 10-2 B. subtilis serial 
dilution (initial input 1800000 CFUs). S. aureus identified as Staphylococcus species in 100% 
of samples when the initial input of bacteria exceeded 275 CFUs. When the initial input of S. 
aureus was less than 275 (Sa-6), the sample identified as Staphylococcus species 0% of the 
time. Negative control, B. subtilis identified as Staphylococcus species at a rate of 0% 
indicating no non-specific binding during IMS methods. Statistical analysis was not conducted 
due to low sample size. 
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Figure 36. Average growth (CFU/ml) of S. aureus by enrichment from swab specimen 
collection over 5 hours. After IMS capture, S. aureus captured by anti-Protein A DynaBeads 
were resuspended in filtered TSB agar and incubated at 37 ͦ C for 5 hours while shaken at 250 
rpm. Each hour, the tubes were magnetically separated for 3 minutes and the supernatant was 
spread plated on TSB agar and incubated at 37 ͦ C for 18 hours. Colony forming units were 
then calculated. At hour 0 of enrichment, average growth was 4.73 x 107 CFU/ml, after 1 hour 
of enrichment average growth was 2.19 x 108 CFU/ml, after 2 hours of enrichment average 
growth was 4.57 x 108 CFU/ml, after 3 hours of enrichment average growth was 2.66 x 109 
CFU/ml, after 4 hours of enrichment average growth was 4.36 x 109 CFU/ml, and after 5 
hours of enrichment average growth was 1.27 x 1010 CFU/ml.  
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DISCUSSION 
 
 
 
 
IMS capture, enrichment, and laser-light scattering identification method 
development  
 
After establishing the methods for rapid S. aureus capture via IMS, we needed to 
combine IMS and laser-light scattering technology in order to rapidly identify S. aureus. 
Previous studies suggest that faster pathogen identification leads to faster administration 
of appropriate treatments, and this has been linked to improved patient outcomes. 
Improved patient outcomes include a reduction in hospitalization time, decreased risk of 
nosocomial infections, and decreased in medical costs 44. After establishing anti-Protein 
A DynaBead IMS capture methods for S. aureus, we developed an enrichment step which 
was performed in order to obtain the proper concentration of bacteria for laser-light 
scattering identification (1,000 bacteria cells per milliliter) 37. The following conditions 
were altered in order to determine optimal conditions for the highest percent identified as 
Staphylococcus species for S. aureus: media type for enrichment, filtration of media for 
enrichment, removal of beads during enrichment, time of enrichment, removal of media 
after enrichment, and resuspension of captured bacteria in filtered water.  
The first attempt at combining IMS, enrichment, and laser-light scattering 
technology, the following methods were utilized: samples were bound by anti-Protein A 
DynaBeads in filtered TSB media at 22 ͦ C, 1-3 hours of enrichment in filtered TSB at 37 ͦ 
C, and magnetic separation of anti-Protein A DynaBeads and direct addition of 
supernatant to MIT vials for laser-light scattering analysis. These variables resulted in S. 
aureus identifying as Staphylococcus species in 30% of samples. In the search to further 
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enhance the rate of S. aureus capture, we found that previous studies had established a 
link between Protein A expression and growth dependence. Previous studies have 
determined that Protein A is expressed on the surface of nearly all S. aureus strains and 
occupies approximately 7% of the S. aureus cell surface and that it is upregulated during 
the exponential growth phase 30,59. We then sought to determine if increasing the 
temperature from 22 ͦ C to 37 ͦ C during the binding procedure between anti-Protein A 
DynaBeads and S. aureus cells would affect the overall capture rate of S. aureus. We 
hypothesized that increasing the binding temperature from 22 ͦ C to 37 ͦ C would lead to an 
upregulation in Protein A on the surface of S. aureus cells present in the sample. The 
upregulation of Protein A would then lead to an increased capture rate of S. aureus by 
anti-Protein A antibodies, ultimately leading to a higher concentration of S. aureus for 
laser-light scattering identification.  After subsequent testing, we determined that 
incubation during anti-Protein A DynaBead binding at 37 ͦ C resulted in S. aureus 
identifying as Staphylococcus species in 36% of samples compared to the 30% without 
incubation.  
To further develop our methods, it has been suggested from previous studies that 
shaking liquid cultures of bacteria helps increase the rate of growth within that sample 38. 
Shaking allows the culture to remain aerated and this provides adequate oxygen for the 
bacteria within the sample, thus increasing the rate of bacterial growth 38. Knowing this, 
we used previously mentioned methods and combined them with agitation. We used two 
different agitation speeds, 215 rpm and 250 rpm, to determine if the addition of agitation 
would enhance the rate of S. aureus growth during the enrichment step. When samples 
were shaken at 215 rpm this resulted in S. aureus identifying as Staphylococcus species 
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in 45% of samples. When samples were shaken at 250 rpm this resulted in S. aureus 
identifying as Staphylococcus species in 44% of samples.   
In order to increase the percentage of S. aureus identifying as Staphylococcus 
species using laser-light scatter, we hypothesized that removing the anti-Protein A 
DynaBeads after hours 1 or 2 of enrichment would aid in accurate laser-light scattering 
identification. Removing the anti-Protein A DynaBeads would potentially result in an 
increase in accurate identification by preventing anti-Protein A DynaBeads from entering 
the MIT sample. If both S. aureus cells and anti-Protein A DynaBeads were added to a 
MIT sample, the laser-light scattering pattern could be altered and identification accuracy 
would decrease. These methods included: IMS methods performed in filtered TSB media 
at 37 ͦ C, 1-2 hours of enrichment in filtered TSB while shaken at 250 rpm at 37 ͦ C, after 
1-2 hours of enrichment, anti-Protein A DynaBeads were removed and the enrichment 
incubation of samples resumed, magnetic separation of anti-Protein A DynaBeads and 
direct addition of supernatant to MIT vials for laser-light scattering analysis. Although 
the DynaBeads were removed, each sample was still magnetically separated for 3 
minutes after enrichment in order to reduce the risk of including DynaBeads into a 
sample. When anti-Protein A DynaBeads were removed after 1-2 hours of enrichment, S. 
aureus identified as Staphylococcus species in 64% of samples. 
In order to determine if we could increase the rate of S. aureus growth during the 
enrichment step, filtered terrific broth was utilized instead of filtered TSB media. Terrific 
broth is a highly enrichment media that is generally used to increase the yield of plasmid 
DNA from transformed microbial strains 19. The following protocol was utilized to 
compare the efficiency of Terrific broth with TSB: IMS methods performed in filtered 
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Terrific broth media at 37 ͦ C, 1-3 hours of enrichment in filtered TSB while shaken at 
250 rpm at 37 ͦ C, after 1-2 hours of enrichment, anti-Protein A DynaBeads were removed 
and the enrichment incubation of samples resumed, magnetic separation of anti-Protein A 
DynaBeads and direct addition of supernatant to MIT vials for laser-light scattering 
analysis.  When IMS and laser-light scattering identification methods were performed in 
filtered Terrific Broth, rather than filtered TSB, S. aureus identified as Staphylococcus 
species in 50% of samples. Due to the reduced percent identification of S. aureus when 
enriched in Terrific Both, we decided to utilized TSB media in future experiments.  
After altering variables to increase the accuracy of laser-light scattering 
identifications of S. aureus, we wanted to determine if removing the anti-Protein A 
DynaBeads and TSB enrichment media would increase the accuracy of identification. 
Knowing the importance of particulates within a MIT sample in laser-light scattering 
patterns, we hypothesized that removing potential laser-light scattering pattern 
particulates could help to increase the rate of S. aureus identification. After altering the 
above variables for IMS capture, enrichment, and laser-light scattering identification, the 
following methods were established as the optimal conditions: IMS methods performed 
in filtered TSB media at 37 ͦ C, 1-5 hours of enrichment in filtered TSB while shaken at 
250 rpm at 37 ͦ C, after enrichment anti-Protein A DynaBeads were removed and so was 
the TSB media (by pelleting the cells in the supernatant), S. aureus cells were then 
resuspended in 10-50 µl of filtered water, vortexed (to break up the bacteria pellet and 
resuspend the bacterial cells) and samples were then added to MIT vials for laser-light 
scattering analysis.  When these conditions were utilized, S. aureus identified as 
Staphylococcus species in 80% of samples (Figure 28). It is worth noting that all sample 
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concentrations (10-2 to 10-6) were included in the average percent identified as 
Staphylococcus species. Samples that were more highly concentrated with S. aureus had 
higher percent identifications as Staphylococcus species.  
IMS capture, enrichment, and laser-light scattering identification  
 
After establishing anti-Protein A DynaBead capture, enrichment, and identification, 
the efficiency of the established rapid identification methods were assessed. The ability to 
capture, enrich, and identify S. aureus was tested on both S. aureus and the negative 
control strains (S. pyogenes, M. luteus, E. faecalis, L. monocytogenes, E. aerogenes, and 
E. coli) in order to evaluate its specificity for S. aureus alone. S. aureus was then mixed 
with negative controls to create a more complex and realistic specimen sample, the 
efficiency of the rapid identification methods was then assessed. For each sample that 
was tested, the average initial input (CFU/ml) of bacteria were determined. 
When IMS capture, enrichment, and single laser-light scattering identification 
methods were performed S. aureus identified as Staphylococcus species via laser-light 
scattering 80% (Figure 29). M. luteus miss-identified as Staphylococcus species via laser- 
light scattering 12.5% of the time. E. aerogenes, E. coli, E. faecalis, L. monocytogenes, 
and S. pyogenes all identified as Staphylococcus species via laser-light scattering 0.00% 
of the time. When comparing S. aureus percent identified as Staphylococcus species 
individually to all negative controls via one-way ANOVA Bonferroni multiple 
comparison tests, statistical significance was found for each negative control, P-value less 
than 0.001. The only negative control that miss-identified as Staphylococcus species was 
M. luteus. Reasoning for miss-identification could be due to the fact that M. luteus cell 
characteristics closely resemble S. aureus cells. M. luteus cells are Gram-positive cocci 
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that are approximately 0.5-3.5 µm in diameter and usually arrange in tetrads or irregular 
clusters and S. aureus cells are gram positive cocci that are approximately 0.6 µm in 
diameter and usually arrange in clusters 4,83. If the M. luteus cells had grown closer to 0.6 
µm in diameter, this could explain why M. luteus identified as Staphylococcus species 
using laser-light scattering. MIT is currently working on developing a Staphylococcus 
aureus identifier, which could help increase the accuracy for S. aureus identification and 
reduce miss-identifications of samples that may closely resemble S. aureus cell 
characteristics, like M. luteus. Although M. luteus miss-identified as Staphylococcus 
species 12.5% of the time, we hope that our IMS capture and washing methods could 
help remove these unbound or non-specifically bound cells in future experiments.     
In order to increase the complexity of our laboratory made samples, S. aureus was 
combined with negative control strains and IMS capture, enrichment, and laser-light 
scattering methods were utilized in order to assess the efficiency of our methods for S. 
aureus isolation from mixed samples. All of the polymicrobial results (Figure 30) were 
then compared to the results of S. aureus alone (Figure 29). S. aureus identified as 
Staphylococcus species via laser-light scattering 80% of the time. When S. aureus was 
combined with E. aerogenes, it was identified as Staphylococcus species via laser-light 
scattering 50% of the time. When S. aureus was combined with E. coli, S. aureus was 
identified as Staphylococcus species 0% of the time. When S. aureus was combined with 
E. faecalis, S. aureus identified as Staphylococcus species 50% of the time.  When S. 
aureus was combined with L. monocytogenes, S. aureus was identified as Staphylococcus 
species 60% of the time.  When S. aureus was combined with M. luteus, S. aureus was 
identified as Staphylococcus species 75% of the time.  When S. aureus was combined 
  
115 
 
with S. pyogenes, S. aureus was identified as Staphylococcus species identified 75% of 
the time. In order to generate further complex samples, S. aureus was combined with two 
negative control strains. When S. aureus was combined with S. pyogenes and M. luteus, 
S. aureus identified as Staphylococcus species 75% of the time. When S. aureus was 
combined with S. pyogenes and E.coli, S. aureus identified as Staphylococcus species 0% 
of the time. Statistical significance (P-value < 0.05) was shown when samples containing 
E. coli were compared to S. aureus.   
After analyzing IMS capture, enrichment, and laser-light scattering methods in 
polymicrobial cultures, we determined that when S. aureus was combined with skin 
associated microbes, M. luteus and S. pyogenes, S. aureus was identified as 
Staphylococcus species 75% of the time, compared to 80% when samples contained S. 
aureus alone. However, when S. aureus was combined with E. aerogenes, E. faecalis, L. 
monocytogenes displayed a reduction in percent identified as Staphylococcus species, 
ranging from 50-60% identified as Staphylococcus species. Although there was a 
reduction in percent identified as Staphylococcus species when S. aureus was combined 
with these strains, there was no statistical significance to the reduction (P > 0.05). When 
S. aureus was combined with E. coli, this combination resulted, with statistical 
significance (P < 0.05), in a 0% identification rate for Staphylococcus species.  
In typical wound infections, specimens are collected from these types of infection 
sites on sterile swabs. In order to determine if IMS could successfully capture S. aureus 
from a swab sample, sterile swabs were inoculated with a broth culture containing 
dilutions of S. aureus. The swabs were transferred to a test tube containing and 
previously established capture, enrichment, and identification protocol were used to 
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isolate the bacteria from swab specimens. Since S. aureus is not always isolated in pure 
culture from the site of infection, we created pure and mixed swab samples to replicate 
normal skin microorganisms and IMS capture, enrichment, and laser-light scattering 
identification methods were repeated. In addition, we also combined S. aureus with real 
human skin and nose swabs in order to increase the complexity of the samples and assess 
if our methods could be utilized in complex biological samples. We hypothesize that our 
swab methods would produce results similar to those in pure and mixed culture methods 
(Figures 29-30); however, the average bacterial input would be reduced.    
Our results of pure swab IMS capture, enrichment, and laser-light scattering 
identification displayed that S. aureus identified as Staphylococcus species via laser-light 
scattering 82% of the time (Figure 32). S. pyogenes identified as Staphylococcus species 
via laser-light scattering 10% of the time. E. coli, E. faecalis, L. monocytogenes, M. 
luteus, human nose swab, direct human nose swab, human skin swab all identified as 
Staphylococcus species via laser-light scattering, with statistical significant (P < 0.001), 
0.00% of the time (Figure 32).  
In order to increase the complexity of our laboratory made swab samples, S. aureus 
was combined with negative control strains and IMS capture, enrichment, and laser-light 
scattering methods were utilized in order to assess the efficiency of our methods for S. 
aureus isolation from mixed samples. All of the polymicrobial results (Figure 32) were 
then compared to the results of S. aureus alone (Figure 30). Overall, these results 
displayed similar results to pure and mixed samples (Figures 29 and 30) and E. coli once 
again displayed a significant reduction in percentage identified as Staphylococcus 
species.   
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In both the pure and swab specimen samples, E. coli contributed to a reduction in 
S. aureus identification when mixed with S. aureus. E. coli have multiple virulence 
factors that contribute to its pathogenicity, one of those virulence factors is the fimbriae 
41. The fimbriae, or pili, are involved in adhesion/adherence of E. coli to epithelial cells 
within its host 29,64. Adherence fimbriae are also involved in biofilm formation within the 
epithelial intestinal cells 41. Previous studies have suggested that temperature regulation 
may play a role in the upregulation of fimbriae related genes, thus increasing the presence 
of this adhesion protein on the surface of E. coli 78.     
 When conducting initial anti-Protein A DynaBead specificity for S. aureus, E. coli 
was utilized as one of the negative control strains. It was determined that E. coli, much 
like the other controls strains, had a capture efficiency of less than 1.00% (Figures 29-
33). However, when developing IMS capture, enrichment, and laser-light scattering 
methods we adjusted the binding temperature from 22 ͦ C to 37 ͦ C. This temperature 
change was conducted in order to increase the rate of S. aureus capture by upregulating 
Protein A on the surface of S. aureus and increase the replication rate of S. aureus. The 
known temperature regulation of both Protein A and E. coli fimbriae may result in 
enhanced binding competition. Although we determined that anti-Protein A DynaBeads 
have specificity for S. aureus when bound at 22 ͦ C in pure culture, we speculate that 
increasing the binding temperature could potentially lead to an upregulation in fimbriae. 
The primary function of fimbriae is adhesion and its binding has been found to be non-
specific host tissues, via electrostatic hydrophobic/hydrophilic interactions 20. In addition 
to non-specific binding to host tissues, fimbriae can interact with inanimate objects and 
can often bind fimbriae to fimbriae creating biofilms 20,41,67. We hypothesize that E. coli 
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could have been incorporated in the MIT samples even after the washing step. If E. coli 
was incorporated into the samples undergoing the enrichment step, both S. aureus and E. 
coli growth would occur, resulting in a highly concentrated mixed sample that would not 
identify as S. aureus.  
  The final goal of this section was to quantify the average amount of bacterial 
growth each hour (1-5 hours) during the enrichment step. Figure 36 displays the results 
recorded from this experiment. On average, after 1 hour of enrichment average growth 
was 2.19 x 108 CFU/ml, after 2 hours of enrichment average growth was 4.57 x 108 
CFU/ml, after 3 hours of enrichment average growth was 2.66 x 109 CFU/ml, after 4 
hours of enrichment average growth was 4.36 x 109 CFU/ml, and after 5 hours of 
enrichment average growth was 1.27 x 1010 CFU/ml. By using the average S. aureus 
bacterial input (CFU/ml), we were able to determine the necessary time of enrichment 
needed to produce the appropriate concentration of bacteria for a positive identification 
using laser-light scattering technology. Using the trend line produced in Figure 36 (y = 
6E+07e1.1059x) we determined that with the average S. aureus input (4.86 x 109 CFU/ml) 
via swab specimen collection, 3.36 hours of enrichment was needed to produce a positive 
identification using laser-light scattering technology.  
Future directions 
 
In the future, we hope to increase the rate of S. aureus identification above 95% 
for both pure and mixed cultures and adjust the IMS washing methods to limit non-
specific binding of pileated bacteria (E. coli and E. aerogenes). In order to increase the 
rate of S. aureus identification above 95%, we need to reduce non-specific binding. Non-
specific binding could occur on the walls or caps of the tubes as well as, binding to the 
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anti-Protein A DynaBeads, which could be addressed by modifying the washing 
procedure. By increasing the percentage of Tween included in our PBS wash buffer or 
testing other detergents may aid in reducing non-specific binding.    
In the future we also plan to perform IMS capture, enrichment, and laser-light 
scattering identification on patient swab samples obtained directly from infected wounds 
or soft tissue infections. We hope to perform a single blind experiment, similar to the 
single blind experiment conducted in chapter two, with the addition of IMS capture and 
enrichment directly from patient swab specimens.   
Future directions in combination with our collaborator, MIT, include improving 
the Staphylococcus species Identifier to specifically identify Staphylococcus aureus. 
Currently MIT reports that the S. aureus Identifier is 95% completed. Once the S. aureus 
Identifier is complete the S. aureus Identifier will be validated by testing in the Sharp lab. 
We have over two dozen different S. aureus isolates in our strain collection to test the 
strength of this Identifier. MIT is also making initial light scattering measurement on a 
MRSA strains. We purchased two MRSA panels from the American Type Collection that 
contains 17 different MRSA strains with different sccMec types. It will be interesting to 
determine if MRSA strains have any consistent light scattering pattern differences 
compared to methicillin-sensitive S. aureus (MSSA) strains.  The mecA gene genomic 
insertions that confer methicillin resistance are relatively small, between 2.820-2.903 Mb 
nucleotides and the protein content of the MRSA cell is likely very similar to MSSA 
strains. It may push the limits of the technology to differentiate MRSA from MSSA. MIT 
also plans to automate the methods we have generated. Although this system generates an 
identification for S. aureus faster than traditional methods it is still fairly labor intensive. 
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Automating this system could decrease sample preparation time and labor efforts. 
Overall, this study has generated a novel and rapid method for S. aureus capture and 
identification from pure and mixed swab specimens. Further development of these 
methods could lead to applications in both clinical and dairy industries for faster S. 
aureus identification. By changing the target of the antibody used in our IMS methods, 
there is the potential to apply this technology to any bacteria of interest. 
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APPENDIX A 
 
 
 
 
LETTER OF SUPPORT FROM UP HEALTH SYSTEMS- MARQUETTE 
(FORMERLY MARQUETTE GENERAL) TO USE CLINICAL PATIENT ISOLATES  
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